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Bone remodeling is critical for maintenance of bone health and requires a 
balance of bone resorption by osteoclasts followed with formation by osteoblasts. 
These opposing activities are spatially and temporally segregated and 
coordinated on the bone surface. Chemoattraction between osteoclasts and 
osteoblasts has been extensively investigated and has been proposed to direct 
osteoblasts to the site of bone resorption. However, the mechanism by which 
osteoclasts and osteoblasts are spatially segregated on the bone surface 
remains unknown. In this thesis, I demonstrate that osteoclasts induce contact 
inhibition of locomotion in migrating osteoblasts, which may enable spatial 
segregation of these cells. I identify Semaphorin 4D, expressed on the surface of 
osteoclasts, and its receptor Plexin-B1, expressed by osteoblasts, to be critical 
for the induction of contact inhibition of locomotion. I developed an optogenetic 
tool to initiate Plexin-B1 signaling using blue light, named optoPlexin. Localized 
stimulation of optoPlexin in subcellular regions elucidated spatial and temporal 
dynamics of signaling pathways involved in mediating contact inhibition of 
locomotion. In addition, I used optoPlexin to develop a novel protein-protein 
interaction assay in live cells, which revealed a previously unknown role of the 
RGS-like domain of PDZ-RhoGEF in mediating recruitment by Plexin-B1.  
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Abhijit Deb Roy, PhD 
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This thesis provides new understanding of the interactions between osteoclasts 
and osteoblasts during bone remodeling, illustrates the impact of localized 
Semaphorin 4D-Plexin-B1 stimulation in migrating osteoblasts, and provides new 
information on the molecular mechanism of Plexin-B1 signaling. The 
observations on spatial regulation of signaling pathways in cells undergoing 
contact inhibition of locomotion are pertinent to understanding the molecular 
pathways mediating cell repolarization. Furthermore, the novel optogenetic 
approach utilized to locally stimulate Plexin-B1 may be extended to other plexins, 
and potentially to other repulsive-guidance molecules.  Thus, this work presents 
a significant advance not only in the field of bone biology and semaphorin-plexin 
signaling, but cell biology in general. 
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CHAPTER I 
Introduction  
 2 
Bone and its remodeling 
Bone is a rigid mineralized connective tissue found in vertebrates. It 
provides structure, shape and support to the animal body, protects internal 
organs and enables fast and complex movements of animal limbs. In addition, 
bones act as a reservoir for minerals and growth factors, provides a site for 
maintenance of stem cells and produces different types of cells including red and 
white blood cells. In humans, the load bearing long bones are composed of two 
morphologically distinct types: cortical and trabecular bones. Cortical bones are 
the dense matrix on the cortex of most bones and provide strength by being 
resistant to bending and torsion. Trabecular or cancellous bone form a 
honeycomb-like network inside bones. Trabecular bones are weaker and more 
flexible than cortical bones, and may act as shock absorbers. During movement 
and other load-bearing activities, trabecular bone may undergo localized 
damage. Unless remedied, such damage may accumulate and compromise 
skeletal integrity over time. Bone remodeling, a process by which older bone is 
replaced by new bone plays a critical role in the restoration of bone strength and 
maintenance of skeletal integrity1–3. Bone remodeling primarily involves three 
types of cells: osteoclasts, osteoblasts and osteocytes. 
Remodeling is initiated by resorption of bone by osteoclasts, followed by 
deposition of bone matrix by osteoblasts. Osteocytes may play a role in directing 
osteoclasts to sites of bone resorption4. Resorption and formation of bone matrix 
are quantitatively coupled so that the amount of bone resorbed is replaced by 
deposition3. Imbalances in this coupling can lead to pathological states, the most 
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prominent being osteoporosis marked by a loss of bone mineral density and 
weaker bones making patients prone to fractures. During remodeling, bone 
resorption in damaged trabeculae are spatially and temporally discrete events, 
for proper remodeling it is important that the consequent bone deposition occurs 
at the site of resorption after the resorption is completed and the active 
osteoclasts are no longer present. Such intricate spatiotemporal orchestration of 
osteoclast and osteoblast activities involves many ‘coupling factors’ that regulate 
their migration and differentiation.  
Fracture healing is distinct from bone remodeling. After fracture, there is a 
rapid inflammatory response, followed by proliferation of fibroblasts that form a 
loose connective tissue called granulation tissue. Osteoclasts migrate to the site 
and resorb bone fragments and prepare the broken bone ends for healing. The 
cells in the periosteum, which is the outer layer of bones, proliferate and 
differentiate into chondroblasts and forms collagen rich ‘hyaline cartilage’; and 
osteoblasts, which lay down ‘woven bone’: a form of bone matrix with 
disorganized collagen fibers. As these new collagen matrices close the gap 
produced by the fracture, over time they are replaced by more organized lamellar 
bone matrix and formation of trabecular bone. Finally, over a significantly longer 
time scale, these trabecular bones undergo remodeling to form compact bones 
and the bone is healed to a state close to the pre-fracture form5. 
This section will provide a brief overview of the cells involved in bone 
remodeling, the aforementioned coupling factors and regulation of osteoblastic 
migration to the site of resorption. 
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Bone cells 
Osteoclasts: Osteoclasts are large multinucleated cells of hematopoetic origin 
that degrade bone. Osteoclasts are formed by fusion of mononuclear 
macrophage lineage cells. Receptor activator of nuclear factor kappa ligand 
(RANKL), which is expressed by osteoblastic lineage cells, is critical for 
osteoclastogenesis2,6. Macrophages express RANK, which is activated by 
RANKL from osteoblast-lineage cells. RANKL is generally thought to be plasma 
membrane bound, indicating that cell-cell contact between macrophages and 
osteoblast-lineage cells are critical for osteoclastogenesis (Figure 1a). 
Furthermore, osteoblast-lineage cells also express osteoprotegerin (OPG), which 
acts as a decoy receptor for RANKL, thus inhibiting osteoclastogenesis6. 
Osteoclasts migrate to specific sites  on the bone surface and initiate resorption 
by forming an actin-rich sealing zone and secreting protons to efficiently dissolve 
the mineralized hydroxyapatite component of bone, followed by degradation of 
the collagen matrix by metalloproteases and cathepsins1. Uncontrolled increase 
in osteoclast numbers or activity is associated with osteoporosis and rheumatoid 
arthritis, whereas defects in osteoclast resorption can cause osteopetrosis. One 
common strategy to combat osteoporosis is bisphosphonate treatment, which 
acts by decreasing osteoclast survival and action7. Long term decreases in 
osteoclast viability, and thus severe decreases in bone resorption effectively 
halts remodeling. Such lack of remodeling leads to a ‘frozen bone’ syndrome, 
where damages accumulate in the skeleton, impairing bone integrity and 
increasing the probability of failure. 
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Figure 1. Interactions between bone cells during remodeling. a) Interactions 
between pre-osteoclasts and osteoblastic lineage cells during RANKL mediated 
osteoclastogenesis. b) Chemotaxis of osteoblasts towards the site of resorption. c) 
Repulsion of osteoblasts upon contact with osteoclasts 
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Osteoblasts and osteocytes: Osteoblasts are mesenchymal lineage 
cells that synthesize bone. They are generally spindle shaped or polygonal. 
During bone remodeling, osteoblasts restore the bone removed by osteoclasts by 
the same amount in the same region of resorption, and thus regulate bone 
integrity. Pre-osteoblasts are thought to migrate to site of resorption after the 
osteoclasts have prepared the substrate and moved away, differentiate and 
deposit bone matrix. Over time this matrix gets mineralized bringing the bone 
back to its previous strength, marking the end of the remodeling cycle1. In the 
course of matrix deposition, some of the osteoblasts get entrapped in the matrix 
and terminally differentiate into osteocytes. Osteocytes have a stellate shape and 
are non-motile. They form intricate connected network spanning the bone matrix 
through long extended cytoplasmic processes in the bone canaliculi. Osteocytes 
have been proposed to respond to mechanical loading to coordinate bone 
remodeling, although the molecular mechanisms involved in such signaling 
remains elusive. In-vitro assays with cultivating osteocytic cell lines in matrigel 
have demonstrated their capability of exchanging cytoplasmic material, and may 
be one way by which they secrete cytokines. In addition, recently, osteocytes 
have been demonstrated to express RANKL and proposed to support, if not 
predominantly mediate, osteoclastogenesis4. However, the mechanism by which 
macrophages may access membrane-bound RANKL in osteocytes embedded in 
bone matrix is not well understood. 
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Coupling factors in bone remodeling 
The osteoblastic cells interact with osteoclast precursors and osteoclasts 
at multiple stages during the bone remodeling process. Bone remodeling is 
initiated by osteoclastic resorption. Osteoclastogenesis is regulated by the ratio 
of RANKL and OPG expressed by osteoblast lineage cells. Accounting for the 
highly localized nature of osteoclastic resorption, spatial and temporal regulation 
of osteoblastic migration to the site of resorption is critical for proper bone 
remodeling. The coupling of osteoblasts to osteoclasts may be realized through 
multiple ways. During bone matrix formation, osteoblasts deposit growth factors 
such as PDGF, TGF-β, BMP-2 and IGFs, which are released during osteoclastic 
resorption and may promote osteoblast migration3,8–10. Additionally, osteoclasts 
also secrete factors such as S1P, BMP-6, CTHRC1, and cardiotropin-1 that may 
promote osteoblast migration to the site of resorption3,11,12 (Figure 1b). While the 
focus has been on coupling factors expressed or regulated by either osteoclasts 
or osteoblasts, the bone microenvironment contains many different types of cells, 
which may also secrete some of these factors, thus making the coordination of 
bone resorption and formation much more nuanced and thus, more complex. 
Finally, changes in the topography of bone surface after osteoclastic action may 
also play a role in mediating osteoblast migration and function13,14. 
 Osteoblasts respond to chemoattractants released to locate the site of 
active resorption. Migration of osteoblastic cells to the site of resorption 
presumably happens in different phases: recruitment of osteoblastic progenitors 
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to the bone surface and migration of pre-osteoblasts to the specific site of 
resorption. Resorption is initiated around 4-8 weeks prior to bone deposition 
phase. Since migratory factors released from the bone matrix during the early 
stages of resorption would presumably diffuse away during this period, it is likely 
that these factors recruit of osteoblast progenitors to the bone surface. Once on 
the bone surface, factors released from the matrix as well as those secreted by 
osteoclasts may guide them to the appropriate site. Since osteoclasts and 
osteoblasts are not usually observed the same space on bone surface, we may 
reason that osteoblasts occupy the site of resorption only after the osteoclasts 
have migrated away or undergone apoptosis. In the absence of active 
osteoclasts, there is no obvious source for chemoattractants, and how the pre-
osteoblasts identify the exact location of resorption is not well understood. 
Haptotaxis or durotaxis, or a combination of both may play an important role in 
directing pre-osteoblasts to the resorption pits, but that requires the pre-
osteoblasts to be present on the bone surface prior to completion of resorption. 
Additionally, osteoclasts and osteoblasts have completely opposing functions, 
and express factors that inhibit one another’s differentiation and activity. Thus, 
ideally, the osteoblast progenitors should be recruited to the bone surface, and 
migrate towards but not occupy the site of resorption until the osteoclasts have 
completed resorption. Indeed in vivo, osteoblasts and osteoclasts are observed 
spatially segregated on the bone surface and rarely in contact with one 
another15,16. In the presence of only a chemotactic gradient, osteoclasts and 
osteoblasts should be clustered together. Thus, the current model of bone 
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remodeling does not explain segregation of osteoclasts and osteoblasts on the 
bone surface and fails to give a complete picture of spatial regulation of bone 
remodeling. A combination of chemotaxis and repulsion upon contact between 
the two cell types may be explain how pre-osteoblasts may be recruited to the 
general region of resorption and yet be kept away from sites with active 
osteoclasts (Figure 1c). Although repulsion-like behavior occurring between 
osteoblasts and osteoclastic cells has been reported intermittently17,18, such 
behavior and the pertinent signaling mechanisms have not been examined.   
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Repulsion between cells 
Directional cell migration is critical for proper embryonic development as well 
tissue homeostasis in adult animals, defects in which may cause disease states. 
Directionality in migration may be achieved by attractive or repulsive cues, 
respectively guiding cells towards or away from a source. Chemoattractive 
factors and chemotaxis in cells have been extensively studied across many 
systems. Chemotaxis is achieved by polarizing a migrating cell to promote and 
stabilize protrusions towards and inhibiting protrusions away from the target. 
Conversely, repulsion may be elicited by destabilizing protrusions towards the 
target and inducing repolarization of the direction of migration. In addition, 
repulsion between cells may occur in response to soluble factors or require 
contact between cells. There were also some early reports of long distance 
repulsion between cells through electrostatic forces19,20; although such 
responses may not be of particular physiological import. 
Repulsion in response to soluble factors was first reported in a response 
of bacterial cells by antimicrobial agents or factors released by neutrophils. 
Soluble repulsive factors may act by countering effects of chemoattractants; 
however, repulsion is not mere inhibition of chemotaxis. Repulsive response in 
eukaryotic cells in response to soluble factors was first reported and has been 
extensively studied in neuronal guidance21. Repulsive factors in neuronal 
development were experimentally studied in the context of axon growth cone 
collapse22–24, which were extended to neurite retractions and collapse of 
protrusions in other cells. In particular Netrins, ephrins, semaphorins and Slit 
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have been have been proposed to play key roles in axonal repulsion based upon 
collapse assays utilizing solubilized ligands22–28. It is noteworthy that Netrin, 
ephrin and semaphorin families have both secreted and plasma membrane 
bound members. Additionally, some of these plasma membrane bound ligands 
may undergo proteolytic cleavage and act as soluble repulsive guidance cues. 
More recently, immune cells have been reported to undergo migration down a 
gradient of growth factors. This phenomenon has been variously called fugetaxis, 
reverse chemotaxis and chemorepulsion. In particular SDF-1, S1P and IL-8 have 
been implicated in repulsion of immune cells29–32. Additionally, Slit has also been 
reported to inhibit response to chemoattractants33. Chemorepulsion of immune 
cells has been proposed to mediate emigration of T-cells from the thymus34, and 
may be utilized by viruses and cancer cells to avoid detection by the immune 
system31,35. Conversely, chemorepulsion may be utilized to reduce rejection in 
organ transplants by utilizing cells expressing repulsive factors in allografts.  
Repulsion between cells was first reported to occur between fibroblasts 
after contact, wherein cells ceased to persist in their direction of motion after 
contact with another cell36. Unlike chemorepulsion mediated by soluble factors 
released into the extracellular environment, repulsion after contact is arguably 
mediated by membrane bound factors and thus may only be effective when two 
cells, expressing the appropriate ligand-receptor pair come in contact. This work 
is mainly focused on contact repulsion or contact inhibition of locomotion (CIL), 
which is discussed in greater details in the following section. 
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Contact inhibition of locomotion 
 Contact inhibition of locomotion (CIL) is the phenomenon where cells 
migrate away from one another following cell-cell contact. Abercrombie and 
Heaysman first reported such behavior in 1953 from their observation of 
migratory behavior of chick fibroblasts in vitro. Abercrombie coined the term 
‘contact inhibition’ to describe their observation of ‘directional prohibition’ of cell 
migration upon contact with other cells36. While significant in its own regard, 
investigation into CIL enabled probing into the fundamental questions of cell 
migration such as persistence, maintenance and changes in front and back 
polarity etc. Shortly after two decades of investigation into its various facets, the 
term ‘contact inhibition’ in context of cell motility as well as investigation into 
repulsion between cells fell out of favour. This was partly due to an increased 
interest in ‘contact inhibition of proliferation’, coined in mid 1960s, which had 
been gaining traction in the scientific community trying to identify differences 
between ‘normal’ and cancer cells grown in culture. Additionally, the 
physiological relevance of CIL was not obvious, and the events that CIL was 
composed of, such as directional cell migration, cell-cell contact, front and back 
polarity of migrating cells were being studied independently37. Furthermore, some 
groups that were studying repulsion between cells were using the term ‘contact 
repulsion’ to avoid confusion with contact inhibition of proliferation. Recently, the 
term CIL has come back in vogue in part due to the efforts of Roberto Mayor, 
whose work focuses on the impact of CIL on directional migration of neural crest 
cells38–40. There is considerable variation in the phenomena that are defined or  
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described as CIL, perhaps due to the originally broad and relatively vague 
definition of CIL as ‘cessation of a cell continuing to migrate in the same direction 
after contact with another cell’ covered, and still covers a wide range of cellular 
behavior. Indeed, it may be easier to describe what CIL is not than what it is. 
When contact with another cell does not alter the direction or magnitude of 
motility of a migrating cell, it has not experienced CIL (Figure 2a).  
Types of contact inhibition of locomotion 
In an effort to define the different responses cells undergo that may be 
ascribed to CIL, it has been proposed to be classified into as many as six types. 
Abercrombie had classified CIL into two types: type I (Figure 2a) involved 
contraction of the leading edge at the site of contact, repolarization and migration 
away from the site of contact; and type II (Figure 2b), which involved inability of a 
cell to move over or across another cell and may involve cessation of movement 
or gliding past the cell in contact37,41. From a molecular signaling perspective, 
type I CIL may be described to involve repolarization induced by signaling 
pathways initiated upon contact, whereas type II may be described as a cell 
migrating away from or around a physical barrier to motility. Although superficially 
distinct, type I and type II may not be entirely independent of one another since 
physical contact between two cells may initiate signaling depending on changes 
in mechanical forces or membrane tension experienced by the cells or the nature 
of the substrate available, and the extracellular environment may modulate the 
response of repolarization signaling initiated upon contact. It is perhaps easier to 
define type I CIL as change in migratory behavior mediated by signaling across 
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two cells upon contact through plasma membrane localized ligand-receptor 
complexes. CIL may be further categorized as homotypic: between similar cells, 
or heterotypic: between different types of cells. Contact between cells of similar 
of different types can yield completely different responses in the same cells. This 
work primarily pertains to type I heterotypic CIL between osteoblasts and 
osteoclasts, and is discussed in details in chapter II.  
Assays to study and quantify contact inhibition of locomotion 
Regardless of the categories and classifications, it is worth remembering 
that CIL is neither discrete nor uniform behavior. It ranges the gamut of cessation 
of motility, moving around another cell or a complete reversal of direction of 
migration. Such wide range of responses makes it particularly tricky to decide 
whether a cellular response is CIL or not. To account for the diverse responses 
that may be CIL, researchers have utilized different experimental assays and 
analytical approaches to qualitatively and quantitatively study CIL37,42–44. Some of 
them are briefly discussed below. 
Mixing assay: Two different groups of cells or tissue explants are placed 
next to one another, and the degree of overlap between the two groups of cells 
after a certain period of time is measured. Presence of CIL will decrease the 
degree of overlap or mixing of the two groups. The difference in distance 
traversed by cells when placed next to the other group versus alone, or the 
degree of mixing indicates the impact of CIL on their spreading (Figure 3a).  
Radial outgrowth: A group of cells that undergo homotypic CIL will 
spread radially outwards away from their neighbors. This behavior may be  
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Figure 3. Assays to evaluate CIL. (a) Mixing assay, (b) radial outgrowth assay, (c) one 
dimensional kinematics post collision and (d) cell polarization map after collision. 
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utilized to assess CIL in cells by measuring the spread of cells from a relatively 
confluent culture or tissue explant (Figure 3b). This assay is, of course, not useful 
for heterotypic CIL, or if the cells predominantly move collectively. 
Cell-cell contact kinematics: Observing changes in the trajectory of cells 
coming in contact with another can be utilized to assess CIL. In the absence of 
CIL, contact with another cell will have minimal impact of the migrating cells, 
where if CIL occurs, the direction of migration of the cells should be altered 
significantly.  Measurements of such changes in direction upon contact should be 
compared against free moving cells to account for random switches in direction 
in freely moving cells. As an extension, some groups have utilized patterned 
substrates to restrict cell movement in a line42,45, which simplifies quantification of 
CIL (Figure 3c). However, restricting movement in a single line may significantly 
alter cell behavior by changing the threshold required for change in direction.  
Changes in cell morphology and polarity: The basic definition of CIL 
pertains to a change in the state of motion of a cell upon contact with another. 
Observing contacts between migrating cells can enable identification of changes 
in cell morphology and polarity. In particular, a polarity map to identify the 
location of new protrusions formed with respect to the site of contact has been 
used to qualitatively identify CIL (Figure 3d). This may be particularly useful when 
investigating CIL in vivo.  
Each of these assays has their pros and cons. In particular, whether these 
assays are relevant in assessing cell behavior in a three-dimensional in-vivo 
environment remains to be determined. In addition to subjective observation, it is  
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useful to quantify cell behavior to distinguish between CIL and lack of it. Different 
groups have measured the frequency of protrusion collapse upon contact, 
separation between cells and deviation in direction of migration post contact to 
quantify CIL. We have quantified CIL between osteoblasts and osteoclasts using 
all three approaches, which are described in chapter II. 
Molecular mechanisms of contact inhibition of locomotion 
Type I CIL response in cells may be divided into four events that occur 
one after another to orchestrate one seamless response (Figure 4). Obviously, 
these events are neither independent of nor separated from one another and 
there may be different degrees of overlap depending on context. Nevertheless, it 
may be useful to utilize these subjectively defined stages of CIL to delve into the 
molecular pathways that regulate CIL. 
Cell-cell contact: Type I CIL presumably involves activation of signaling 
pathways in the cell through membrane bound molecules on the other cell 
(Figure 4a). This would require a relatively stable cell-cell contact. Recent studies 
have pointed at the role of cadherins in formation of cell-cell junctions46,47. 
Furthermore, other proteins that mediate formation of adherens junctions such as 
vinculin, p120, α-catenin and β-catenins have also been reported to play different 
roles in CIL37,39,48. However, these proteins are also involved in making stable 
cell-cell contacts, and the reason behind the transience of the junctions in CIL is 
not well understood. One possibility is the role of different cadherins in organizing 
stable versus transient junctions. In particular, E and N-cadherin have been 
respectively proposed to mediate stable contacts and repulsion between cells. 
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Wnt-Frizzled signaling may be engaged upon cell contact. Furthermore, 
engagement of other membrane-bound molecules may modify or over-ride the 
nature of cell-cell contacts. In particular repulsive guidance molecules such as 
Ephrins and Eph receptors and SLIT-ROBO signaling have been implicated in 
mediating CIL between cells37,49,50. In a similar vein, here I have attempted to 
demonstrate the role of Semaphorins and Plexins, more specifically Semaphorin 
4D and Plexin-B1 in mediating CIL. Aside from cadherins, how much this ligand-
receptor coupling may stabilize cell-cell contact is not known. Since the very 
nature of CIL implies a relatively short contact between cells, how such ligand-
receptor pairs identify these sites of contact is an interesting question. It is 
possible that diffusion on the plasma membrane enables accumulation at the site 
of contact, which in turn is stable until a critical threshold of repulsive signal is 
achieved.  
Collapse of protrusions: Cell-cell contact and cessation of protrusions at 
the site of contact, in order, are hallmarks of CIL. Members of the Rho family of 
small GTPases are well known regulators of front and back polarity in cells. More 
specifically, Rac1 and Cdc42 are known to promote actin polymerization and 
protrusions, whereas RhoA is generally thought to promote myosin driven 
contractility to inhibit protrusions and mediate retractions. In addition, 
phosphatidylinositols, which are lipid components of the plasma membrane are 
also involved in regulation of protrusions and retractions through cross-talk with 
small GTPases. Cessation or collapse of protrusions involves inhibition of Rac1 
and/or Cdc42 activities at the leading edge (Figure 4a, 4b). The precise 
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mechanism of such inhibition is not well understood, although it is possible that 
different pathways may engage different molecules to inhibit Rac1 and Cdc42. N-
Cadherin, PAR3 and Dishevelled have been reported to mediate Rac1 inhibition 
in Neural Crest cells39,51–54. Ephrin and Eph receptor mediated CIL may involve 
activation of RhoA, which has an inhibitory relationship with Rac1. Although 
cross-talk between small GTPases55, in particular that between RhoA and Rac1 
(and Cdc42) seem to be consistent across many instances of CIL, the exact 
molecular signaling pathways that mediate such crosstalk need further 
elaboration.  
Repolarization: Inhibition of protrusions at the site of cell-cell contact is 
usually followed by increased contraction, converting the former protrusion into a 
retraction. Around the same time, a new protrusion is formed away from the site 
of contact that causes the cell to repolarize (Figure 4c). It may be speculated that 
such repolarization primarily involves spatial reorganization of the factors that 
maintain front and back polarity in a migrating cell. RhoA activation appears to 
play a critical role in the induction of contractility at the site of contact. Such 
contractility may result in increased mechanical tension around the region of 
contact, which has been observed in CIL between Drosophila macrophages56. In 
addition, RhoA may activate PTEN57, which is a known inhibitor of 
phosphoinositide-mediated protrusions. Additionally, increased tension in the 
actin cytoskeleton may also induce repolarization of cells through 
mechanosensitive signaling pathways, although the precise mechanism of such 
repolarization remains to be elucidated. Repolarization of the cell also involves 
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reorientation of microtubules away from the site of contact towards the new 
protrusions. In Drosophila marcophages, microtubule catastrophe around the site 
of cell-cell contact has been observed, but the signaling mechanism involved in 
this reorientation is not currently known56. Although simple in concept, 
repolarization of a cell involves reorganization of all the essential cytoskeletal 
components: actin, microtubules and plasma membrane, and thus potentially 
involves a large degree of crosstalk across the pathways that mediate these 
different cytoskeletal elements, the precise nature of which is currently not well 
understood.  
Migration away from the site of contact: Once repolarized, the cells 
may continue to migrate away from the site of contact (Figure 4d). While positive 
feedback may be involved in maintaining the front and back after repolarization, 
the physical separation of the cells involves disruption of the cell-cell junction, 
active retraction and stabilization of new protrusions away from the site of 
contact. Since protrusions are stabilized by integrin mediated adhesions, focal 
adhesions may be spatially regulated to enable persistent migration. Migration of 
cells away from the site of contact may involve a simple disruption of adhesions 
or maturation of adhesions followed by dissolution. The nature of adhesions 
depends on cell-type and substrate; more work is needed to understand the role 
played by adhesions in CIL.  
Physiological relevance of contact inhibition of locomotion 
Recently CIL, especially homotypic, has been extensively studied in 
different systems in vitro as well as in vivo.  CIL has been implicated in many  
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physiological phenomena: collective migration, tissue patterning, cell dispersion 
and maintenance of tissue boundaries40,51. CIL may regulate dispersion of Cajal-
Retzius cells and macrophages during embryogenesis58. However, the exact 
positioning of these cells is not random, and perhaps involves an intricate 
balance of homo and heterotypic CIL, as well as other cues present in-vivo. 
Heterotypic CIL may be involved in maintenance of tissue borders. This is 
particularly relevant in cancer metastasis, since loss of CIL may enable 
malignant cells to effectively migrate into tissues. Although loss of CIL has been 
proposed to promote invasiveness of cancer cells in vitro, whether the same 
happens in vivo remains to be further examined. A shift from E-Cadherin to N-
Cadherin mediated cell-cell contacts correlates with both induction of CIL and 
EMT51, although any direct connections between the two phenomena remain to 
be examined. Macrophages show an interesting behavior, wherein they appear 
to undergo homotypic56, but not heterotypic CIL51. This might be explained by 
their role in looking for sites of infection or wounds where homotypic CIL enables 
greater spread, and lack of heterotypic CIL enables tissue penetration to 
effectively migrate to the site of injury. However, how the macrophages may 
overcome homotypic CIL to aggregate at sites of injury is not known. Unlike cell 
dispersion, the role of CIL in collective migration, although perhaps counter-
intuitive, is particularly fascinating (Figure 5). Heterotypic CIL may enable greater 
directional persistence of a collectively migrating group of cells by restricting 
spread. In addition, homotypic CIL in the presence of co-attraction between 
migrating cells may enable efficient protrusion formation and maintenance only in 
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cell-free regions (Figure 5). A combination of homotypic and heterotypic CIL 
between placode cells and neural crest cells has been demonstrated to be critical 
for a ‘chase and run’ behavior that may be critical during embryogenesis. Such 
behavior might explain how cells can efficiently respond to relatively low 
concentrations of chemoattractants to migrate to their destination. The molecular 
mechanisms that lead to collective migration versus cell dispersal stemming from 
a seemingly similar phenomenon are not well understood.   
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Semaphorin and Plexin signaling  
Membrane bound repulsive ligand receptor pairs are of particular interest 
in CIL. Ephrins and Eph receptors, and semaphorins and plexins are arguably 
the most well studied families of repulsive guidance factors. My work is primarily 
focused on Semaphorin 4D and its receptor Plexin-B1, and this section will 
provide a brief introduction to semaphorin and plexin signaling.  
Functional domains of semaphorins and plexins 
Semaphorins are a group of membrane associated or secreted 
glycoproteins, which have been categorized into eight groups. Semaphorins 
expressed by invertebrates are categorized in groups 1 and 2, and the last group 
is reserved for semaphorins expressed in viruses. In vertebrates, semaphorins 
have been classified into groups 3 to 7, of which group 3 are secreted and the 
rest are membrane associated. Group 4 semaphorins may have an intracellular 
PDZ domain, which may be involved in reverse signaling through plexins (Figure 
6). All semaphorins have a conserved extracellular ‘Sema’ domain, which shows 
structural similarities to β-propeller repeats in α-integrins. Sema domains are 
found in the extracellular regions of semaphorins, plexins, and receptor tyrosine 
kinases Met and Ron. Plexins are a group of transmembrane proteins and are 
the major receptors for semaphorins. Based on sequence homology plexins have 
been classified into four groups: A-D. All plexins share a largely homologous 
structure (Figure 6): an extracellular sema domain with which they form 
heterodimers with semaphorins, a single transmembrane helix, a juxtamembrane 
region followed by a RasGAP homology region and a RhoGTPase binding  
 27 
 
  
 
 
R-Ras 
GDP 
R-Ras 
GTP 
Rac1 
GTP 
RhoA 
GTP 
RhoA 
GDP 
PDZ-RhoGEF 
PBM 
RBD 
Ras
GAP
 
Sema 
Sema 
PBD 
C1 C2 RBD PBM TM Sema JM 
PBM TM Sema 
Semaphorin 4D 
Plexin-B1 
Figure 6. Semaphorin 4D and Plexin-B1 domains and signaling. Sema, sema 
domain. TM, transmembrane domain. PBM, PBZ binding domain (same as PBD or 
PDZ binding domain). JM, juxtamembrane domain. C1, C2, halves of RasGAP 
domain of Plexin-B1. RBD, Rho GTPase binding domain.  
 
 28 
domain (RBD). The RasGAP domain is unique in that the domain is divided into 
two segments, referred to as C1 and C2, with each segment containing one of 
the catalytic arginine residues critical for RasGAP action. C1 and C2 are 
connected by an unrelated RBD that associates with GTP-loaded Rho GTPases. 
Although the linear sequence C1 and C2 are separated by about 200 amino 
acids, structural studies do not reflect any such separation, with C1 and C2 
segments cohesively forming a RasGAP domain and the RBD shifted away. The 
juxtamembrane region folds into a helix-loop-helix conformation and aligns 
between the RasGAP domain and the RBD. Additionally, B family plexins have a 
C-terminal PDZ binding domain (PBD) with which they can recruit and activate 
PDZ-domain containing RhoGEFs: PDZ-RhoGEF and Leukemia associated 
RhoGEF (LARG). Plexin-D1 also has a C-terminal PBD, and has been recently 
reported to recruit and activate GIPC1 (GAIP interacting protein, C-terminus 1) 
through interaction with its PDZ domain. GTPase binding to plexin-RBD is critical 
for the RasGAP activity of plexins. For this reason, plexins are thought to function 
as AND gates, integrating extracellular as well as intracellular signals. All 
semaphorins, except group 3, directly associate with plexins through their sema 
domains. Group 3 semaphorins require neuropilins as a co-receptor for 
association with plexins. Neuropilins are single pass transmembrane proteins 
with a size of ~900 amino acids. They have very short intracellular regions, and 
are generally thought to function primarily as a co-receptor for plexins and 
receptors for vascular endothelial growth factors (VEGFR). Whether they directly 
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mediate any signaling pathways independent of semaphorins, plexins or 
VEGFRs is not well known60–62.  
All plexins have a RasGAP domain through which they may inhibit Ras 
GTPases. In particular, A and B family plexins have been reported to inhibit R-
Ras, M-Ras and Rap1 GTPases through its RasGAP domain. Although R-Ras 
was the first Ras GTPase reported to be regulated by plexin RasGAP domain, 
there is some controversy about whether it is indeed directly inhibited by 
plexins63–65. Rho GTPase binding to plexin-RBD regulates its RasGAP activity. 
As mentioned earlier, B-family plexins recruit PRG and LARG through their C-
terminal PBD leading to activation of RhoA66–68. Although the interaction between 
Plexin PBD with the PDZ domain of the RhoGEFs is thought to be constitutive68, 
GTPase binding to plexin-RBD has been reported to promote RhoA activation69. 
The molecular mechanism of GTPase regulation of plexin signaling is not well 
understood. This is particularly interesting since structural studies have reported 
minimal conformational changes upon Rac1 binding to Plexin-A1 or Plexin-B1 
RBD70. Recently, Rac1 and Rnd1 have been reported to bind to a second region 
of Plexin-B1 that is proximal to the site of Ras binding. This additional interaction 
between Rac1 or Rnd1 with plexins has been proposed to promote a trimeric 
conformation of Plexin-Ras complex71.  
Group 4 semaphorins have a short intracellular region (~ 20 amino acids) 
and have a putative PBD in their C-terminus, which raises the possibility of a 
reverse signaling pathway with Plexins acting as the ligand. In immune cells, 
Sema4D was reported to associate with a tyrosine phosphatase CD4572. 
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Sema4C and Sema4F interact with PSD-95 in neurons73,74. Whether these 
associations are dependent on plexin remains to be investigated. Recently, 
Plexin-B1 has been reported to act as a ligand for Sema4A, promoting interaction 
between Sema4A intracellular domain and Scrib through a PBD-PDZ 
interaction75. This association was proposed to competitively inhibit the formation 
of β-Pix-Scrib complex, leading to inhibition of Rac1 activity. This in turn has 
been proposed to be critical for promotion of cell migration by Plexin-B1, 
although how inhibition of Rac1 could lead to migration was not explained.  
 Family 6 semaphorins have the largest intracellular domain of all 
semaphorins, and some of these have proline rich sequences, which may act as 
docking sites for SH3 domains. Sema6D intracellular domain forms a molecular 
complex with ABL tyrosine kinase through its SH3 domain, and this interaction is 
promoted by Plexin-A176. Src kinase may similarly bind with Sema6B77. In 
addition to plexins, semaphorins may also have other lower affinity receptors. For 
example, Sema4A and Sema4D bind with receptors TIM2 and CD75 in immune 
cells78. Whether these receptors may induce reverse signaling through 
semaphorins remain to be investigated. Also, the sema domains of semaphorins 
and plexins share certain structural homology with extracellular domains of α-
integrins, and might associate with β-integrins to activate FAK or other 
associated kinases60. However, the exact nature of such association and 
downstream signaling needs further investigation. 
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Tyrosine kinase activation by plexin signaling 
 Semaphorins can activate tyrosine kinases through plexins, and may act 
as a non-canonical activator for these kinases79. Specific plexins may associate 
with different kinases, resulting in differential regulation of downstream signaling, 
and cellular response. These associations are dependent on the types of cells, 
with the same plexin associating with different kinases in different cells. In 
dendritic cells and pre-osteoclasts, Plexin-A1 has been reported to activate 
intracellular tyrosine kinase SYK through a complex formation with TREM2 and 
DAP1280. In neurons and COS-7 fibroblast-like cells, A-family plexins associate 
with Fes and Fyn kinases leading to growth cone or cell collapse81. In the cardiac 
system, depending on the cell type, Plexin-A1 may associate with either 
VEGFR2 or with OTK to promote or inhibit migratory behavior82. As mentioned 
earlier, neuropilins associate with VEGFR, and may regulate complex formation 
with Plexin-As83,84. In addition, neuropilins have been implicated in semaphorin 
dependent recruitment of FES and FAK kinases85. Sema4D has been reported to 
activate ErbB2 or Met through co-clustering with Plexin-B1 through their 
extracellular domains in different cells. Activation of either Met or ErbB2 can 
phosphorylate unique tyrosine residues on Plexin-B1 intracellular domain, and 
also have opposite effects on RhoA activation. This differential signaling leads to 
opposite outcomes in cell behavior, with ErbB2 activation associated with 
increased motility and Met activation leading to decreased motility86–88. 
Conversely, Sema5A induced association of Plexin-B3 with Met has been 
reported to promote both cell collapse as well as increased motility89. Sema4D-
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Plexin-B1 signaling has also been reported to activate Src and Pyk2 kinases, 
although the molecular pathways connecting these molecules are not currently 
well understood90. 
Plexin signaling in physiology and pathology 
 Although semaphorins and plexins were first identified as a family of 
repulsive guidance molecules, they are now recognized to play different roles in 
different physiological systems; and dysregulation of their signaling is associated 
with many pathological states91. Indeed, semaphorins have been reported to act 
as both attractive and repulsive cues. For example, Sema3A may induce 
collapse of growth cones as well as promote neurite outgrowth92,93. Inhibition of 
Sema3A appears to support neural regeneration in instances of corneal 
transplant and spinal injuries94,95. Plexins were initially studied in the context of 
neuronal guidance. Consistent with their role as repulsive guidance cues, 
semaphorins often define regions of exclusion for corresponding plexin 
expressing neurons in the brain. Sema4D, Sema7A, Plexin-A1 or Plexin-B1 
knock-out mice show reduced susceptibility to development of experimental 
autoimmune encephalitis, an experimental model for multiple sclerosis91. In 
cultured neurons, Sema4D-Plexin-B1 signaling has been proposed to regulate 
dendritic spine density and maturation through RhoA-ROCK signaling96. 
Sema3E-Plexin-D1 signaling has been demonstrated to negatively regulate 
synapse formation in vivo97.  
 Plexins play diverse roles in angiogenesis. A-family plexins have been 
reported to promote angiogenesis by promoting motility of endothelial cells. 
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Surprisingly, this enables both fusions of smaller vessels to form large ones, as 
well as division of vessels to form smaller ones that are more spread out to cover 
a larger surface area60. Plexin association with VEGFR has been proposed to 
promote angiogenesis. Conversely, Plexin-D1 acts as a negative regulator for 
angiogenesis, with Sema3E marking regions of exclusion for vasculature98,99. 
Sema4A and Sema4D were the first semaphorins identified in immune cells. In 
addition to plexins, these semaphorins may utilize Tim2 and CD72 to modulate 
immune cell behavior. The major impact of plexin signaling on immune cells may 
be mediated by the RasGAP activity on Ras molecules and subsequent 
modulation of integrin engagement60,91. Sema4D has been reported to inhibit 
migration of monocytes and dendritic cells through Plexin-B1100. Viral 
semaphorins show the greatest homology with Sema7A, which is expressed by 
immune cells60. Sema7A knock-out mice show resistence to West Nile virus 
infection101,102. Vaccinia virus semaphorin (A39R) activates Plexin-C1 signaling, 
and has been demonstrated to inhibit migration of monocytes and dendritic cells 
towards virus-infected cells, and also inhibit phagocytosis103,104. HIV-1 infection 
increases Sema4D expression in dendritic cells, which may promote further 
infection105.  
 In particular due to association with tyrosine kinases and Ras signaling, 
plexins have been studied in the context of cancer biology.  Plexin-A1 has been 
implicated in promoting malignancy in lung cancers106. Plexin-A1 and Plexin-A4 
have also been implicated in promotion of tumor growth through its promotion of 
angiogenesis91,107–109. Sema4D produced by tumor cells has been reported to 
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attract Plexin-B1 expressing endothelial cells into the tumor microenvironment 
and promote angiogenesis, leading to increased tumor growth110,111. However, 
the exact mechanism by which Sema4D may act as an attractant is remains 
unexplained. Knock-out of Plexin-B1 reduces instances of metastases in ErbB2-
positive breast cancer in a mice model112. Antibody mediated inhibition of Plexin-
B2 also reduced tumor growth in a mouse model113. Similarly, knockdown of 
Sema3E, or its receptor Plexin-D1 in cancer cells has been reported to reduce 
metastasis in a mouse xenograft model114–116. Semaphorins and plexins are now 
increasingly being investigated for their roles in skeletal biology117. Sema3A 
knock-out mice show an osteopenic phenotype118, whereas Plexin-A1 knock-out 
mice have increased bone mass80. Sema4D, Plexin-B1 or Plexin-B1 null mice 
have an osteopetrotic phenotype15,119. Soluble Sem4D treatment has been 
shown to inhibit osteoblast differentiation in vitro, and may also regulate 
osteoclast function. Anti-Plexin-B1 antibodies are being investigated for 
therapeutic use in osteoporosis120. As discussed earlier, spatial regulation of cell 
migration is particularly relevant in the context of bone remodeling. Although 
there is a good deal of information available about semaphorin and plexin 
signaling pathways through biochemical assays, little is known about the spatial 
regulation of plexin signaling, which is particularly significant in its role as a 
repulsive guidance molecule. My work focuses on spatial regulation of Plexin-B1 
signaling in osteoblasts, and its impact on directional migration. It is discussed in 
details in Chapter II.
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Spatial control of signaling pathways 
Conventional approaches of studying the impact of a ligand on cell motility 
usually involve ligand perfusion in culture and observing changes in cell 
morphology or motility. Boyden chamber assays have been utilized to 
characterize the response of cells to chemo-attractants and repellents. However, 
such assays often involve concentration gradients far beyond physiologically 
relevant levels, and do provide little information regarding the spatial and 
temporal coordination of cell polarizing events that enable directional response to 
these stimuli. Repulsive interactions between cells have in particular been 
predominantly studied by utilizing bath application of soluble ligands with an 
expectation of a cell or protrusion collapse as the end point. More recently, 
microfluidic devices have been utilized to get greater control of concentration 
gradients45; but such control often comes with the caveat of movement restricted 
in a single dimension. CIL has been investigated by investigating collisions 
between randomly migrating cells, and utilizing ligand immobilized on solid 
beads. Since contact between cells may engage many signaling pathways, it is 
difficult to establish causality utilizing cell-cell interaction, especially in the 
absence of stark phenotypes. Although ligand-coated beads may alleviate such 
concerns, collisions in a culture sparse enough to observe single cell behavior is 
a low probability event, which makes investigating spatial regulation of signaling 
events particularly difficult. Recently, optogenetic approaches have been 
successfully used to achieve spatial and temporal resolution in initiating signaling 
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pathways in vitro and in vivo. Some of these approaches are discussed in this 
section. 
Optogenetic toolkits for cell biology 
Optogenetics is generally defined as genetically encoded tools expressed 
in living cells (or animals) that enable the use of light to drive signaling pathways. 
In other words, optogenetic tools are light dependent actuators of molecular 
pathways. The prototypical optogenetic tool was based on plant 
channelrhodopsin2 that was utilized in cultured mammalian neurons to generate 
light mediated membrane currents121,122. Since then, many more optogenetic tools 
have been developed for use in the context of neuroscience. Genetic encoding 
enables expression of the light sensitive proteins in specific neurons. Since only 
these particular neurons are now sensitive to illumination, light can now be used 
as a trigger to map out the neural network and effects of specific neuronal circuits 
in cellular response and animal behavior. Huge strides have indeed been made in 
our understanding of relationship between animal behavior and specific neural 
circuits. In addition to the basic research and understanding, optogenetic 
approaches are being investigated to design light based therapies. Light 
dependent stimulation enables better temporal control than conventional 
approaches, and also allows spatial restriction of signaling pathways to subcellular 
regions. Furthermore, many optogenetic tools are reversible in nature, enabling 
investigation of cyclic activation of pathways. These particular properties make 
optogenetic approaches highly desirable in understanding spatiotemporal 
regulation of signaling pathways in cells.  Optogenetic tools to activate specific 
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signaling cascades are usually developed using chimera proteins with light 
sensitive modules that undergo a desirable change upon illumination and the 
proteins of interest whose signaling should be activated upon illumination. In this 
section, I will briefly discuss some of the optogenetic modules that have been 
developed and utilized in the recent years to understand spatial and temporal 
regulation of signaling pathways in the field of cell biology.  
LOV domain: The Light-Oxygen-Voltage domains are blue-light sensitive 
(~440-470 nm) protein domains that are found in plant, bacterial, algal and fungal 
species. LOV domains contain a Period-ARRNT-singleminded (PAS) domain core 
with a flavin cofactor. Light activation of the flavin cofactor leads to unfolding of the 
C-terminal J-α helix and undocking from the PAS core123,124. This conformational 
change in the LOV domain was exploited to successfully design many optogenetic 
modules. Photoactivatable Rac1 (PA-Rac1) based on the LOV2 domain of Avena 
sativa phototropin1 (AsLOV2) was the first genetically encoded tool for activating 
a small GTPase using light125. PA-Rac1 adopts an autoinhibited conformation in 
dark, wherein the LOV-domain would sterically block the effector-binding domain 
of a constitutively active mutant of Rac1 (Figure 7a). Upon blue light activation, the 
J-α helix unwinds to expose the effector-binding domain, which is now available to 
initiate downstream signaling cascades. Localized activation of PA-Rac1 induced 
membrane ruffling and directional migration in cells, in vitro and in vivo125,126. The 
AsLOV2 domain has been utilized to develop an optogenetic module (iLID) that 
undergoes hetero- 
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dimerization upon illumination127. iLID dimerization module utilizes high affinity 
protein hetero-dimerization pairs: seven amino acid residues from bacterial SsrA 
protein that shows structural homology with the J-α helix was fused at the C-
terminus of the helix (Figure 7b). In the dark, the J-α helix occludes the SsrA 
residues from binding with another bacterial protein SspB, and this inhibition was 
relieved upon light dependent unwinding of the J-α helix. In addition, point 
mutations were introduced in the AsLOV2 and SspB domains to modulate the dark 
and light affinity of the iLID components. The iLID dimerization module has been 
utilized to efficiently translocate proteins from one cellular compartment to another. 
Conversely, another AsLOV2 domain based optogenetic hetero-dimerization 
module (LOVTRAP) was recently developed that exists as a dimer in dark, and 
undergoes dissociation in light128 (Figure 7c). LOVTRAP module may be utilized 
to sequester exogenously expressed proteins to specific cellular compartments in 
dark, and release them into the cytosol using light dependent dissociation.  
Vivid and Magnets:  Vivid (VVD) is a fungal LOV domain from the 
filamentous fungi Neurospora crassa. VVD utilizes a flavin cofactor for 
photoactivation, and undergoes homodimerization upon blue light activation 
(Figure 8a). Of the many optogenetic dimerization (or oligomerization) modules 
currently available, VVD is the smallest in size. However, because it forms a weak 
homodimer, it is difficult to use VVD for efficient and specific translocation. 
Furthermore, VVD has very slow dark recovery rates129. Recently, targeted 
mutations were applied to the dimerization interface of VVD to increase the  
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number of either positively or negatively charged residues130. This produced two 
distinct VVD variants that would preferably heterodimerize through electrostatic 
interactions. In addition, other mutations were applied to the VVD molecule to 
significantly improve its dark recovery kinetics. This new VVD based 
heterodimerization module is called Magnets (Figure 8b). AsLOV2, PhyB and Cry2 
based dimerization modules (discussed next) have a disadvantage in that only one 
of the molecules is photoresponsive, and so it may be difficult to maintain a very 
tight spatial control due to diffusion of photoactivated dimers. Magnets have the 
unique property that both the molecules undergoing dimerization are 
photosensitive, which may enable better spatial control compared to other 
optogenetic modules. Unlike other dimerization modules, Magnets interact through 
electrostatic interactions, and that might limit their usage in case of target proteins 
with highly charged surfaces.  
PhyB-Pif: Phytochrome B (PhyB) is another plant photoreceptor that is 
activated by red light (650 nm) and inactivated by far red light (~750 nm). For 
activation, PhyB requires a phycocyanoblin (PCB) cofactor, which is synthesized 
by photosynthetic organisms131. When exogenously expressed in mammalian 
cells, PCB must be externally supplied such that PhyB may auto-catalytically ligate 
with PCB and become photosensitive. Upon red light activation, PCB bound PhyB 
can bind to a transcription factor called Phytochrome interacting factor 6 (PIF6) 
(Figure 9). This heterodimer is stable for hours in dark, and can be induced to 
rapidly dissociate by illumination with far red light (~750 nm). Although the 
inducible reversibility of the PhyB-PIF6 toolkit is  
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particularly attractive, the need to add an exogenous co-factor to ‘complete’ the 
system makes it cumbersome, especially since the purity of the PCB can have a 
big impact on the efficiency of light response. On the other hand, this may be used 
to one’s advantage, since unlike other optogenetic modules, there is no need to 
exclude light from experimental samples until PCB is made available.  Recently, 
biosynthetic enzymes have been designed that may be exogenously expressed in 
mammalian cells to produce PCB.  
Cyrptochrome-2: Cryptochrome 2 (Cry2) from Arabidopsis thaliana is 
another plant photoreceptor that is activated by blue light (~400-490 nm). Cry2 
utilizes endogenously expressed flavin molecule for activation. Cry2 responds to 
blue light by undergoing homo-oligomerization to form protein clusters (Figure 9a) 
and hetero-dimerization with a transcription factor Cryptochrome interacting basic 
helix-loop-helix protein (CIB1) (Figure 9b). These unique responses make Cry2 
particularly attractive in developing light dependent hetero-dimerization and/or 
clustering modules132–134. Similar to iLID and the PhyB-PIF system, the hetero-
dimerization property of Cry2-CIB1 enables recruitment of a protein of interest to 
a specific compartment. Cry2 has a relatively slow off-rate in dark (minutes) 
compared to iLID (seconds). Although this restricts the usage of Cry2 module for 
rapid switching between on and off states, it also allows for maintenance of 
localized photoactivation with lesser degree of illumination, and enables 
investigating changes in other signaling molecules. A point mutation that 
significantly enhances the oligomerization property of Cry-2 (Cry2-olig) has been 
utilized to activate robust clustering upon photoactivation135. 
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All of these optogenetic modules have been utilized to develop tools to 
photoactivate different signaling cascades in living cells and animals, ranging from 
transcriptional regulation to directional migratory response. I have used the Cry2-
CIB1 module for optogenetic activation of Plexin-B1 signaling in cells, and 
discussed the details of the tool design in Chapter II.  
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CHAPTER II 
Optogenetic activation of Plexin-B1 reveals contact-repulsion between 
osteoclasts and osteoblasts 
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Abstract 
During bone remodeling, osteoclasts induce chemotaxis of osteoblasts and yet 
maintain spatial segregation. We show that osteoclasts express the repulsive 
guidance factor Semaphorin 4D and induce contact inhibition of locomotion (CIL) 
in osteoblasts through its receptor Plexin-B1. To examine causality and elucidate 
how localized Plexin-B1 stimulation may spatiotemporally coordinate its 
downstream targets in guiding cell migration, we develop an optogenetic tool for 
Plexin-B1 designated optoPlexin. Precise optoPlexin activation at the leading 
edge of migrating osteoblasts readily induces local retraction and, unexpectedly, 
distal protrusions to steer cells away. These morphological changes are 
accompanied by reorganization of Myosin II, PIP3, adhesion and active Cdc42. 
We attribute the resultant repolarization to RhoA/ROCK-mediated redistribution 
of β-Pix, which activates Cdc42 and promotes protrusion. Thus, our data 
demonstrate a causal role of Plexin-B1 for CIL in osteoblasts and reveals a 
previously unknown effect of Semaphorin signaling on spatial distribution of an 
activator of cell migration. 
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 Introduction 
In multicellular organisms, migrating cells respond to attractive or repulsive 
cues to precisely control speed and directionality and reach their destination with 
spatial and temporal accuracy. Contact inhibition of locomotion (CIL) describes the 
repulsive effect on a migrating cell upon contact with another cell. CIL has been 
implicated in many physiological and pathological phenomena such as embryonic 
development, tissue patterning, collective migration and cancer metastasis. While 
CIL has long been observed in vitro17,36,136 and recently in vivo47,56,58,59,137, the 
precise spatial and temporal dynamics of the underlying signaling remain obscure.  
Guidance molecules such as semaphorins have been proposed to mediate 
repulsion in vivo44,66,138,139. In vertebrates there are 5 classes of semaphorins, 
numbered from 3 to 7, each comprising of several members60. Excluding 
Semaphorin 3s, which are secreted, most semaphorins are either transmembrane 
or membrane-tethered proteins, suggesting a prerequisite role of cell-cell contact in 
their signaling. Semaphorins signal primarily through the Plexin family of single-
pass transmembrane receptors60. Semaphorins interact with plexins through their 
respective extracellular sema domains61,140. The binding is thought to relieve 
autoinhbition of the receptor and mediate clustering of plexin intracellular 
domains71,141,142. The intracellular region of plexins contains a RasGAP domain 
that inactivates R-Ras63. B family plexins contain a PBZ binding domain (PBD) at 
their C-terminus through which they associate with two PDZ-domain containing 
RhoGEFs, PDZ-RhoGEF (PRG) and Leukemia-associated RhoGEF (LARG), and 
activate RhoA67,68,143.  
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During bone remodeling osteoclasts release different factors to mediate 
chemotaxis of osteoblasts to the site of resorption144,145,8,9. Semaphorin 4D 
(Sema4D) expressed by osteoclasts, has been shown recently to regulate 
osteoblast-mediated bone formation15,119.  Ablation of Sema4D or Plexin-B1 
reduced the spacing between osteoclasts and osteoblasts in vivo15, suggesting 
that osteoclasts may also repel osteoblasts, which is contrary to the paradigm of 
chemoattraction between the cells. Whether osteoclasts induce repulsion in 
osteoblasts has not been directly demonstrated and the molecular pathways that 
may mediate such response have not been explored.  
In the current study, we demonstrate that osteoclasts repel osteoblasts 
upon contact and determine that CIL between these cells is dependent on 
Sema4D-Plexin-B1 signaling. To elucidate the spatiotemporal dynamics of Plexin-
B1 downstream effectors that mediate repulsion, we develop an optogenetic tool 
(optoPlexin) to initiate Plexin-B1 signaling at precise times and subcellular 
locations. In contrast to a collapse phenotype upon whole cell activation, localized 
optoPlexin stimulation induces a coordinated retraction at the site of illumination 
and protrusions at distal regions. Similar to CIL with osteoclasts, the repulsion 
phenotype induced by precise optoPlexin stimulation does not alter the inherent 
motility of the cells. Employing biosensors for Myosin II, PIP3 and Rho GTPases 
including RhoA, Cdc42 and Rac1, we define the spatial and temporal regulation of 
signaling downstream of Plexin-B1. Finally, we identify a novel mechanism by 
which Plexin-B1 coordinates cell repolarization through RhoA-ROCK mediated 
redistribution of β-Pix.   
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Results 
Osteoclasts induce contact inhibition of locomotion in osteoblast. 
 To examine whether osteoclasts affect osteoblast migration, we isolated 
primary bone marrow macrophages (BMMs) and primary calvarial osteoblasts 
(POBs) from mice. Upon differentiation in culture, the BMMs formed multinucleated 
osteoclasts and were then overlaid with POBs. Similar to earlier reports, we 
observed that the osteoclasts pushed the obsteoblasts away upon contact17,18. 
There were physical gaps between these two cell types and the osteoblasts lacked 
lamellipodial protrusions toward the osteoclasts (Figure 11a, Movie 1).  To 
investigate how osteoblast migration was altered, we performed a “wound healing” 
assay (Figure 12a, b) in which POBs or MC3T3-E1 cells were seeded next to 
osteoclasts. On removing the insert, both POBs (Movie 2) and MC3T3-E1 cells 
(Movie 3) formed lamellipodial protrusions and migrated towards the osteoclasts. 
Upon contact with osteoclasts, these protrusions rapidly collapsed, followed by 
formation of new protrusions away from the site of contact and a change in 
migration direction (Figure 11b, 12d, Movies 2, 3). In MC3T3-E1 cells, the 
protrusions collapsed on average 6 minutes after initiation of contact with 
osteoclasts and new distal protrusions formed about a minute after (Figure 13a). 
While the migration speed before and after contact remained unaltered (Figure 
13b), the contact acceleration index (Cx, see methods for details) showed a clear 
reversal of migration direction with respect to the trajectory before contact 
(negative values). The Cx approached zero prior to contact indicating directional  
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Figure 11. Osteoclasts repel osteoblasts on contact. (a) Phase contrast images 
showing separation between osteoclasts and osteoblasts in a co-culture. The inset 
(106 μm X 92 μm) is magnified on the right panel to show the gap between the 
osteoclast and the osteoblasts and the lack of protrusions in osteoblasts. The arrows 
point towards the osteoblasts. (b) Phase contrast images showing contact between 
an osteoblast and an osteoclast. The inset is magnified to show changes in cell 
morphology and migration between time of contact and 20 and 40 minutes after 
contact. White triangle points to the site of cell-cell contact. Scale bar, 50 μm.  
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  Figure 12. Plexin-B1 mediates CIL between osteoclasts and osteoblastic cells.  (a) 
Cartoon representation of culture inserts used for co-culture of osteoclasts with 
primary osteoblasts or MC3T3-E1 cells. (b) Phase contrast images acquired 
immediately and 12 hours after lifting the culture insert showing migration of MC3T3-
E1 cells towards osteoclasts. Scale bar, 50 μm. (c) Comparison of Plexin-B1 expression 
in wild type (WT), Cas9, KO1 and KO2 MC3T3-E1 cells. Tubulin was used as a loading 
control. (d), (e) Phase contrast images showing a MC3T3-E1 WT (d) or MC3T3-E1 KO1 
(e) cell in contact with an osteoclast (OC). Insets are magnified to show changes in cell 
morphology and migration between time of contact and 20, 30 and 40 minutes after 
contact. Scale bar, 50 μm. White triangles point to the site of cell-cell contact. (f) 
Percentage of WT, Cas9, KO1 and KO2 MC3T3-E1 cells that show collapse of 
protrusions within 30 minutes after contact with an osteoclast. n = 209-301. (g) 
Separation between MC3T3-E1 cells and osteoclasts 40 minutes after contact. n = 41-
45. (h) Cartoon describing contact acceleration index (Cx). (i) Cx values for WT cells, 
Cas9, KO1 and KO2 MC3T3-E1 cells without (WT only) and after contact with 
osteoclasts. n = 20. For g and I means ± s.e.m. are shown. *** p<0.001, * p<0.05, NS, 
not significant, Student’s t-test. 
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Figure 13. Characterization of CIL between osteoclasts and osteoblasts (a) Delay in 
initiation of retraction at the site of contact and initiation of new distal protrusions in WT 
MC3T3-E1 cells upon contact with osteoclasts. n=85 cells, mean ± s.e.m. are shown. (b) 
Velocities of MC3T3-E1 cells coming in contact with osteoclasts, normalized to the 
velocity right before contact at time 0 . n=29 cells, mean ± s.e.m. are shown. *** p<0.001, 
* p<0.05, NS, not significant. 
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Figure 14. Sema4D/Plexin-B1 expression and knock-out strategy (a) Comparison of 
Sema4D mRNA expression in pre-osteoclasts (BMMs treated with M-CSF) and 
osteoclasts (BMMs treated with M-CSF and RANKL) from Cd1 and C57BL/6 mice. 
Osteoclastogenesis was confirmed by visual inspection of formation of 
multinucleated cells on fourth day of RANKL treatment. und, undetectable. (b) 
Comparison of Plexin-B1 mRNA expression in MC3T3-E1 cells and primary calvarial 
osteoblasts from C57BL/6 mice. mRNA were extracted after 7 and 14 days of 
phosphoascorbate mediated differentiation. (c) Comparison of Plexin-B1 expression 
in MC3T3-E1 and pimary calvarial osteoblasts from C57BL/6 mice after 7 and 14 
days of maintenance in differentiating media. COS-7 cells overexpressing Plexin-B1 
were used for positive control. (d) Comparison of Plexin-B1 expression in WT 
MC3T3-E1 cells and MC3T3-E1 cells stably expressing shRNA against Luciferase (Luc) 
or Plexin-B1 (sh1, sh2 and sh3). (e) Comparison of Plexin-B1 expression in WT 
MC3T3-E1 cells and cells transiently transfected with a non-targeting siRNA pool 
(Ctrl) or Plexin-B1 siRNA pool (PlxnB1). (f) Cartoon representation of the sgRNA 
design strategy for CRISPR-Cas9 mediated Plexin-N1 knock out (see main text). (g) 
Comparison of PCR product using primer 1 and 2 on genomic DNA in WT, Cas9, KO1 
and KO2 MC3T3-E1 cells to probe for deletion targeted by sgRNA1 and sgRNA2.   
For a & b means ± s.e.m. are shown, n=3 wells of cells. *** p<0.001, * p<0.05, NS, 
not significant. For c, d and e tubulin was used as a loading control.  
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Figure 15. Pre-osteoclasts do not induce CIL in osteoblasts (a) Phase contrast images 
showing contact between a MC3T3-E1 cells and a BMM. (b) Percentage of MC3T3-E1 
cells that show collapse of protrusions within 30 minutes after contact with a BMM or 
an osteoclast. n ≥ 40. ***, p<0.001. (c), (d) Phase contrast images showing contact 
between MC3T3-E1 Cas9 (c) or MC3T3-E1 KO2 (d) cell and an osteoclast. The inset is 
magnified to show changes in cell morphology and migration between time of contact 
and 30 minutes after contact. Scale bar, 50 μm. White triangles point to the site of 
cell-cell contact.  
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Table 1. List of primers used for CRISPR-Cas9 mediated Plexin-B1 knock-out 
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persistence (Figure 12h, i). Thus our data indicates that osteoclasts induce CIL in 
obsteoblasts without compromising their intrinsic motility.   
Plexin-B1 mediates osteoclast-induced CIL in osteoblasts 
 Sema4D is expressed by BMMs upon differentiation to osteoclastic lineage 
using Receptor activator of nuclear factor κ-B ligand (RANKL). Consistent with 
previous reports15,119, Sema4D expression was undetectable in BMMs, but was 
markedly increased during RANKL-mediated osteoclastogenesis (Figure 14a). In 
support of a role of Sema4D in CIL, BMMs failed to induce collapse of protrusions 
or change in direction of migration in MC3T3-E1 cells (Figure 15a, b, Movie 4). 
Both POBs and MC3T3-E1 cells expressed Plexin-B1 and no significant changes 
were observed in mRNA or protein levels upon differentiation (Figure 12c, 14b, c). 
To examine whether CIL between MC3T3-E1 and osteoclasts was mediated by 
Plexin-B1, we conducted knock-down experiments with several independent 
shRNA lentivirus, siRNA pools as well as CRISPR/Cas9-mediated knock-out 
experiments.  Despite our best efforts, only modest silencing of protein expression 
(Figure 14d, e) was achieved with siRNA and shRNA without compromising cell 
motility. In contrast, the CRISPR/Cas9 mediated knockout approach (see Methods 
for details) completely eliminated Plexin-B1 expression (Figure 12c).  Two Plexin-
B1 null MC3T3-E1 clones, KO1 and KO2, were used in cell migration assays. 
Cas9 expression alone did not affect Plexin-B1 expression (Figure 12c), nor did it 
alter osteoclast-mediated contact repulsion of MC3T3-E1 cells (Figure 12f, 15c, 
Movie 5). KO1 and KO2 cells failed to show collapse of protrusions upon contact 
with osteoclasts and maintained contact with osteoclasts for prolonged periods of 
 58 
time (Figure 12e, f, 15d, Movies 6, 7). Furthermore, KO1 and KO2 cells did not 
migrate away from the osteoclasts (Figure 12g). Finally, comparison of Cx values 
(Figure 12i) indicated that in contrast to WT and Cas9 cells, KO1 and KO2 cells 
failed to undergo repulsion after contact. Thus our data demonstrated that Plexin-
B1 is required for CIL in osteoblastic MC3T3-E1 cells.  
Development of an optogenetic tool for the Plexin receptor 
To activate Plexin-B1 in osteoblasts, we initially attempted several Sema4D ligand 
based approaches. Perfusion of soluble Sema4D-Fc ligand induced RhoA 
activation in MC3T3-E1 cells and cell collapse as indicated by loss of protrusions 
and decrease in total cell area (Figure 16). Contact between osteoclasts and 
osteoblasts may initiate Sema4D-Plexin-B1 signaling specifically at the site of 
contact. To understand the role of Plexin-B1 in CIL, we locally pumped Sema4D-
Fc near protrusions of POBs using a microinjection pipette (Figure 17). The cells 
responded with a blunted protrusion or retraction locally and 4 out of 5 times 
produced a new protrusion(s) in distal regions, which is consistent with CIL. In 
contrast, no significant morphological changes were observed with control IgG1 
(Figure 17). Because it is difficult to confine soluble ligand in the medium, we used 
immobilized Sema4D-Fc on silica beads as localized sources of Sema4D 
stimulation. Despite rapidly clustering Plexin-B1 on the plasma membrane (Figure 
18, Supplementary Movie 8), the Sema4D-Fc beads failed to induce RhoA 
activation, morphological changes or even recruit RhoGEFs (Figure 19, 20, see 
Methods for details).  
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Figure 16. Sema4D induces RhoA activation and cell collapse in osteoblastic cells. (a) 
Ratiometric images showing changes in morphology and RhoA activation in MC3T3-E1 
cells expressing DORA-RhoA on treatment with 200 nM Sema4D-Fc or hIgG1. Scale 
bar, 10 μm. (b) Changes in cell area of MC3T3-E1 cells treated with 200 nM Sema4D-Fc 
or 200 nM hIgG1, normalized to cell area before treatment. n ≥ 11 cells. (c) Changes in 
RhoA activity of MC3T3-E1 cells treated with 200 nM Sema4D-Fc or 200 nM hIgG1, 
normalized to activities before treatment. n ≥ 11 cells. (d) Temporal changes in RhoA 
activity in MC3T3-E1 cells treated with 200 nM Sema4D-Fc. n=17 cells. For b,c and d 
means ± s.e.m. are shown. *** p<0.001, * p<0.05, NS, not significant. 
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Figure 17. Localized perfusion of Sema4D induces CIL-like repolarization in primary 
osteoblasts. Representative DIC images showing changes in morphology in murine 
calvarial osteoblasts from C57BL/6 mice upon localized Sema4D-Fc or hIgG1(control) 
perfusion. Calvarial osteoblasts were differentiated for 7 days before imaging. 1 μM 
Sema4D-Fc or hIgG1 was perfused at protrusions using positive pressure through a 
micropipette. Local perfusion of Sema4D-Fc induced local retractions and distal 
protrusions in osteoblasts (4 out of 5). No morphological changes observed in 
response to local perfusion of hIgG1 (3 out of 3). Scale bar, 10 μm. Asterisk, induced 
retraction. Arrowhead, induced protrusion. 
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Figure 18. Sema4D immobilized on silica beads clusters Plexin-B1. DIC and wide-field 
fluorescent images showing changes in Plexin-B1-mCherry distribution in COS-7 cells 
before and 10 minutes after contact with Sema4D-Fc (a) or hIgG1 (b) immobilized on 
silica beads. Scale bar, 10 μm. The insets are magnified to show changes in 
distributionPlexin-B1-mCherry around Sema4D-Fc beads or hIgG1 beads. Scale bar, 5 
μm. (c) mCherry intensity in 5 μm circle around beads and beads free cell body after 
10 minutes of contact with beads, normalized to intensity in beads free regions. n ≥ 
70 regions, mean ± s.e.m. are shown. (d)  Percentage of beads that show clustering of 
mCherry around it. n ≥ 230 beads. (e) Temporal changes in Plexin-B1-mCherry 
clustering around Sema4D-Fc beads. n= 5 cells, mean ± s.e.m. are shown. *** 
p<0.001, * p<0.05, NS, not significant. 
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Figure 19. Sema4D immobilized on silica beads fails to activate RhoA (a) DIC and 
ratiometric images showing changes in morphology and RhoA activation in MC3T3-E1 
cells expressing DORA-RhoA before and after contact with Sema4D-Fc beads. Scale bar, 
10 μm. (b)  Changes in RhoA activity of MC3T3-E1 cells after 10 minutes of contact with 
Sema4D-Fc of hIgG1 beads, normalized to activities before contact. n ≥ 7 cells, means ± 
s.e.m. are shown. *** p<0.001, * p<0.05, NS, not significant. 
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Figure 20. Sema4D immobilized on silica beads fails to recruit RhoGEFs. DIC and 
wide-field fluorescent images showing changes in mVenus-PRG (a) or mVenus-LARG 
(b) distribution around Sema4D-Fc beads in COS-7 cells exogenously expressing 
Plexin-B1 with mVenus-PRG or mVenus-LARG. Scale bar, 10 μm. (c) Percentage of 
beads that show mVenus clustering around it. n ≥ 90 beads. (d) Comparison of 
Sema4D-Fc bound to silica beads. (e) Analysis of the western blot in (c) to assess 
the amount of Sema4D-Fc bound to the silica beads. Gray circles indicate the 
standards. Red square corresponds to the intensity of the beads dilution 1/10. (f) 
Cartoon representation of hemisperic contact between Sema4D-Fc silica beads and 
cells and subsequent Plexin-B1 clustering around the beads. (g) Cartoon 
representation of the estimated distance between Sema4D-Fc molecules 
immobilized on a silica beads.  
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To mimic local initiation of Sema4D signaling, we used an optogenetic approach 
to activate the plexin receptor. We took advantage of the observations that both 
the RasGAP activity of Plexin-B1 and its activation of RhoA require its 
localization to the plasma membrane and that semaphorin-dependent clustering 
of plexin promotes its activation71,141,142. A recently characterized optogenetic 
module Cryptochrome-2 (Cry2) was used with a farnesylated Cryptochrome 
interacting basic helix-loop-helix 1 (CIB1-CAAX), to induce a plasma membrane 
translocation of cytosolic proteins in response to blue light132. Furthermore, Cry2 
oligomerizes in light, and could be used to induce protein clustering133. We 
constructed a chimera protein containing Cry2 at the N-terminus, followed by a 
fluorescent protein (mCherry or mVenus), and finally the intracellular domain 
Plexin-B1 at the C-terminus (Figure 21), which preserved its interaction with PRG 
and LARG. Full-length Cry2 was used to minimize background activity in the 
dark37. Because the engineered Plexin-B1 was designed to be activated by light 
instead of Sema4D ligand, we named it optoPlexin (Figure 21, 22a). 
 To examine whether optoPlexin undergoes a plasma membrane 
translocation in response to light stimulation, we co-expressed mCherry-optoPlexin 
and CIB1-CAAX in COS-7 cells and used total internal reflection fluorescence 
(TIRF) microscopy to gauge the membrane association of optoPlexin. Upon blue 
light (440 nm LED) illumination over the entire cell, mCherry intensity increased 
immediately after the first pulse of illumination. The rate of increase appeared to be 
at a similar time scale as Cry2 alone and, with our illumination protocol of 10 
second intervals, reached half maximal intensity within three pulses, indicating a 
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rapid recruitment of optoPlexin to the plasma membrane (Figure 22b top panel, 23, 
Supplementary Movie 9 left panel). The average increase in the intensity of 
optoPlexin and optoPlexin mutants (Figure 21) were close to two-fold, 
indistinguishable from that of Cry2 alone (Figure 22c, 24). Additionally, optoPlexin 
formed clearly visible fluorescent aggregates, indicating clustering of optoPlexin 
(Figure 22d, Figure 25). A flavin adenine dinucleotide (FAD)-deficient mutant of 
Cry2 (D387A) that does not absorb blue light146 failed to recruit optoPlexin 
(Supplementary Movie 9 right panel). Since a lack of FAD may potentially 
compromise the folding of Cry2 or optoPlexin, we also examined an alternate 
mutation of Cry2 (D393A) which preserves the FAD-binding pocket but eliminates 
the proton donor (Asp393) for FAD and blocks signal transduction of crytochrome in 
plants147,148. No membrane recruitment took place for either Cry2 alone or 
optoPlexin carrying the D393A mutation (Figure 22c), demonstrating that the 
observed effects were specific to the photoreaction of Cry2. More effective 
recruitment, an average induction of 4-fold within the region of illumination (Figure 
22b,c), was observed when illumination was limited to a 5 μc-diameter circle 
within the cells. These data demonstrated that optoPlexin can be efficiently 
recruited to the plasma membrane and cluster in response to light stimulation. 
Robust activation of RhoA by optoPlexin on light stimulation 
Upon Sema4D stimulation, Plexin-B1 interacts with and activates PRG or LARG 
through its C-terminal PBD and consequently activates RhoA66,68,143. To test 
whether optoPlexin could interact with PRG and LARG, we examined the 
membrane recruitment of these two RhoGEFs by co-expressing mVenus-PRG or 
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mVenus-LARG in COS-7 cells. Upon whole-cell illumination, we observed a rapid, 
concurrent co-recruitment of PRG (Figure 26a, b, Supplementary Movie 10) or 
LARG (Figure 26b) with optoPlexin to the plasma membrane. The kinetics of PRG 
recruitment and dissociation from the membrane closely followed that of 
optoPlexin. Co-recruitment of PRG was reversible upon pausing blue light 
illumination, and repeatable with a second round of illumination (Supplementary 
Figure 23). An increase in fluorescence of 26% ± 3% and 60% ± 6% (mean ± 
s.e.m.) relative to that of optoPlexin were observed for PRG and LARG 
respectively (Figure 26b), suggesting an efficient recruitment of RhoGEFs to the 
plasma membrane by optoPlexin. Since optoPlexin may also interact with 
endogenous PRG and LARG, the extent to which signals were transmitted from 
optoPlexin to these two RhoGEFs were most likely underestimated. When Cry2 
alone was used as a control, no membrane recruitment of these two RhoGEFs 
was detected (Figure 26b). Illumination of cells expressing a PBD-truncated mutant 
(delPBD) (Figure 21) showed no increase of PRG levels on the plasma membrane 
(Figure 26c) indicating that PBD-PDZ interaction mediates RhoGEF association 
with optoPlexin. The interaction between optoPlexin and PRG did not appear to be 
constitutive. Upon illumination PRG formed quantifiable aggregates (see Methods 
for details) along with optoPlexin in addition to membrane recruitment (Figure 25). 
When we omitted the CIB-CAAX from optoPlexin, the clustering of optoPlexin 
remained visible using TIRF imaging but we did not detect any clustering of PRG 
(Figure 26d, e), suggesting that membrane translocation is critical for activation of 
optoPlexin. 
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Figure 21. Functional domains of optoPlexin and its variants. A diagram depicting 
the domain organization of Plexin-B1, optoPlexin and its mutants. Plexincyto, 
intracellular domain of Plexin-B1. WT, wild type. Sema, Sema domain. TM, 
transmembrane region. JM, juxtamembrane region. C1 and C2, N and C-terminal 
halves of Plexin-B1 RasGAP domain. RBD, Rho GTPase binding domain that binds to 
Rac1 and Rnd1. PBD, PBZ binding domain. FP, fluorescent protein. PRR, proline rich 
region. aa, amino acids. 
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Figure 22. Design and characterization of optoPlexin.  (a) Cartoon representation of 
the optoPlexin design (see main text). FP, fluorescent protein, Plexincyto, cytosolic 
domain of Plexin-B1. (b) TIRF images showing the plasma membrane recruitment of 
mCherry-optoPlexin in COS-7 cells after one minute of whole cell or local illumination 
(440 nm and 50 ms pulse at 0.1Hz, unless otherwise stated). Scale bar, 10 μm. White 
circle, region of illumination. (c) Quantification of the recruitment levels of Cry2, 
Cry2(D393A), optoPlexin and optoPlexin(D393A) on whole cell or localized blue light 
illumination in COS-7 cells. n = 12-20, means ± s.e.m. (d) TIRF images showing the 
clustering of mCherry-optoPlexin after one minute of whole cell illumination in COS-7 
cells. Scale bar, 10 μm. NS, not significant, Student’s t-test. 
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Figure 23. OptoPlexin and PDZ-RhoGEF recruitment kinetics. Temporal changes in 
membrane recruitment and dissociation of mCherry-optoPlexin and mVenus-PRG 
in response to intermittent whole cell illumination in a COS-7 cell. Blue line, 
illumination at 440 nm. 
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Figure 24. Recruitment levels of optoPlexin and its variants. 
Recruitment levels of optoPlexin, optoPlexin-delPBD, optoPlexin-RA, 
optoPlexin with 5 μM erlotinib and optoPlexin-YF on whole cell blue 
light illumination in COS-7 cells, normalized to recruitment level of 
optoPlexin. n ≥ 15, means ± s.e.m. are shown. *** p<0.001, * p<0.05, 
NS, not significant. 
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Figure 25. OptoPlexin and PDZ-RhoGEF clustering. (a) TIRF images showing 
changes in mCherry-optoPlexin clustering (left panels) in COS-7 cells before and 
after whole cell illumination. Images in right panel were passed through a 5X5 
median filter to obtain ‘smooth’ images (middle panels). Changes in clustering 
upon illumination was visualized (right panels) by normalizing the raw images 
(left panels) to the filtered images (middle panels) to minimize effects of cell 
topology. Scale bar, 10 μm. (b) Temporal changes in optoPlexin clustering 
normalized to clustering levels prior to illuminination. Blue line, illumination. 
n=14 cells, mean ± s.e.m. are shown. 
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Figure-26. OptoPlexin activates RhoA through membrane recruitment of RhoGEFs.  (a) 
TIRF images showing the membrane recruitment of mVenus-PRG along with mCherry-
optoPlexin after one minute of whole cell illumination in COS-7 cells. Scale bar, 10 μm. 
(b) Relative co-recruitment of mVenus-PRG or LARG by Cry2 and optoPlexin upon whole 
cell illumination in COS-7 cells, n = 13-19. (c) Normalized relative co-recruitment of 
mVenus-PRG by optoPlexin (n = 19) and optoPlexin-delPBD (n=13). (d) TIRF images 
showing clustering of optoPlexin, and lack of that with mVenus-PRG, in the absence of 
CIB-CAAX after one minute of whole cell illumination in COS-7 cells. Scale bar, 10 μm. (e) 
Quantification of clustering of optoPlexin and PRG in the presence (n = 19) or absence of 
CIB-CAAX (n = 13). (f) Induction of mCherry-optoPlexin upon ratiometric imaging of 
DORA-RhoA biosensor using TIRFM. Scale bar, 10 μm. (g) RhoA activation in COS-7 cells 
expressing Cry2, optoPlexin,  optoPlexin-delPBD or optoPlexin-YF upon whole cell 
illumination, n = 18-32 cells. For b, c, e & g, means ± s.e.m. are shown.*** p<0.001, * 
p<0.05, NS, not significant, Student’s t-test  
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Figure 27. OptoPlexin activates RhoA. (a) TIRF images showing changes in 
mCherry-optoPlexin and Dora-RhoA biosensor induction in COS-7 cells normalized 
to the first frame. Scale bar, 10 μm. (b) Temporal changes in optoPlexin 
stimulation and Dora-RhoA biosensor activity in COS-7 cells. Excitation 
wavelengths used for donor (CFP) and FRET images were sufficient for whole cell 
induction of optoPlexin. Mean ± s.e.m are shown, n=32 cells. 
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Figure 28. PRG recruitment by optoPlexin is not mediated by ErbB2 activation. TIRF 
images showing the membrane recruitment of mVenus-PRG and (a) mCherry-
optoPlexin + 5 μM erlotinib or (b) mCherry-optoPlexin-YF after one minute of whole 
cell illumination in COS-7 cells. Scale bar, 10 μm. (c) Induction of mVenus-PRG 
relative to that of optoPlexin, optoPlexin + 5 μM erlotinib and optoPlexin-YF upon 
whole cell illumination in COS-7 cells, n ≥ 15 cells, mean ± s.e.m. are shown. *** 
p<0.001, * p<0.05, NS, not significant. 
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To directly test whether RhoA was activated upon optoPlexin stimulation, 
we employed the Dora-RhoA biosensor described previously42,43. Due to 
overlapping wavelengths, the excitation light for Dora-RhoA FRET sensor was 
sufficient to induce rapid membrane recruitment of mCherry-optoPlexin in COS-7 
cells (Figure 25, 26f upper panel). Although this prevented us from accurately 
capturing the level of RhoA activation prior to illumination, a consistent increase of 
RhoA activation was readily detectable (Figure 3f lower panel, 27), with an average 
of 70% induction of RhoA activation within the first three acquisitions (Figure 26g, 
27b). Spatial pattern of RhoA activation did not accurately match with optoPlexin 
recruitment levels, potentially due to spatial regulation of RhoA activation through 
other factors. Consistent with being further downstream of Plexin-B1, the activation 
of Dora-RhoA exhbited a delay (~20s) in comparison with the membrane 
recruitment of optoPlexin (Figure 27b). Importantly, the effects were specific 
because no RhoA activation was detected when Cry2 alone or optoPlexin-delPBD 
was used, or when CIB-CAAX was omitted (Figure 26g). Sema4D dependent 
ErbB2 association with Plexin-B1 mediates downstream RhoA activation in 
osteoblasts15,86,149. However, neither inhibiting ErbB2 with Erlotinib150 nor 
mutations designed to abrogate ErbB2 regulation of Plexin-B1149 (optoPlexin-YF) 
(Figure 21) had any negative  impact on PRG co-recruitment (Fig 28a, b); in fact 
we observed increased PRG recruitment in both cases (Figure 28c).  OptoPlexin-
YF induced RhoA activation at levels comparable to optoPlexin-WT(Figure 26g).  
Based on these results, we concluded that optoPlexin exhibits minimal background 
activity in the dark and activates RhoA robustly upon illumination.  
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Induction of CIL upon local activation of optoPlexin 
To precisely control where Plexin-B1 is activated, we expressed optoPlexin 
and CIB-CAAX in MC3T3-E1 cells, and illuminated a 5-μm circular region in 
protrusions to mimic contact with Sema4D-expressing osteoclasts. As optoPlexin 
continued to accumulate, the illuminated protrusion collapsed and started to retract 
(Figure 29a, indicated with an asterisk, Supplementary Movie 11). The effects of 
optoPlexin were better illustrated in kymograph analyses where the accumulation 
of optoPlexin and the sharp transition of the cell border became apparent (Figure 
29c). Despite similar enrichment in the illuminated protrusions, optoPlexin-delPBD 
failed to induce retraction (Figure 29b, c, Supplementary Movie 13), suggesting 
RhoA activation is required for optoPlexin-induced retraction. Among the 
optoPlexin-expressing cells, the average delay from the start of illumination to 
initiation of retraction was 2.5±0.5 minutes (mean ± s.e.m., Figure 29d). 
Interestingly, in addition to retraction, we observed either formation of a new 
protrusion(s) (Figure 29a, indicated with an arrowhead) or enhancement of an 
existing protrusion(s) distal to the site of illumination. They appeared immediately 
after the initiation of retractions, with an average time delay of 75 seconds (Figure 
29d, e), suggesting that they may be mechanistically coupled. Even though 
optoPlexin induced retraction locally (Figure 30a), the overall cell area remains 
unchanged (Figure 30b).  
To quantify the effects of optoPlexin on motility, we superimposed images of 
the cell boundary before and 7.5 minutes after illumination, and determined the 
relative orientations of the illumination site, retraction and protrusion with respect to 
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the centroid of the cell immediately prior to illumination (Figure 30d). Retractions 
were closely aligned with the orientation of the illumination site (Figure 30e, g), 
whereas new protrusions were randomly distributed (Figure 30f, g). Since the 
centroid is dictated by the original cell shape, thereby influencing the relative 
orientations of protrusion and retraction, we also measured the linear distance 
between protrusive or retracting regions and the site of illumination (Figure 30d). 
Retractions took place within 10 microns of the site of illumination, as compared to 
protrusions, which were significantly farther from the site of illumination (Figure 
30h). Persistent illumination in protrusions effectively repolarized the cells and and 
significantly altered their direction so that the cells migrated away from the region 
of illumination (Supplementary Figure 31a, Supplementary Movie 12). In some 
cases we had to change the region of illumination to new protrusions to effectively 
guide the cells.  Tracing the displacements of the centroid and the nucleus of one 
such cell showed a gradual change in centroid direction preceding a sharp change 
in the direction of nuclear migration (Figure 31b, c). Consistent with our 
observations with osteoclast co-culture (Figure 13b), we did not observe significant 
changes in cell centroid or nuclear velocities in MC3T3-E1 cells upon optoPlexin 
stimulation (Figure 30c,32). By contrast, whole cell illumination of optoPlexin-
expressing cells led to collapse of all existing protrusions and hindered motility 
(Movie 14), similar to the response on bath application Sema4D-Fc (Figure 16a, b). 
Thus, localized Plexin-B1 signaling through optoPlexin stimulation revealed a CIL-
like phenotype in MC3T3-E1 cells that had not been demonstrated previously. 
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Figure 29. OptoPlexin induces CIL upon local activation.  MC3T3-E1 cells 
expressing mCherry-optoPlexin (a) or mCherry-optoPlexin-delPBD (b) were locally 
illuminated as indicated (white circle). The DIC and TIRF images were shown to 
illustrate the morphological changes and local membrane recruitment. Scale bar, 
10 μm. Asterisk, retraction. Arrowhead, induced protrusion. (c) Kymographs 
showing cell border progression upon local activation of optoPlexin or optoPlexin-
delPBD. Reference lines for the kymographs are shown in white in (a) and (b). 
Scale bar, 10 μm. (d) Pairwise comparison of the delay in initiation of retractions 
and protrusions upon local optoPlexin activation. (e) Mean delay in initiation of 
local retractions and distal protrusions on local optoPlexin activation. n = 11 cells, 
means ± s.e.m. are shown. *** p<0.001, * p<0.05. NS, not significant, Student’s t-
test. 
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Figure 30. Effects of local activation of optoPlexin on cell morphology and motility.  
Effects on the illuminated protrusions (a), measured in a 50 μm diameter circle 
centered at the region of illumination, and total cell areas (b) after 7.5 minutes of 
local illumination in MC3T3-E1 cells expressing Cry2, optoPlexin, optoPlexin-delPBD, 
optoPlexin and pretreated with 10 μM Y-27632 ROCK inhibitor, and optoPlexin-RA, n 
= 9-14 cells. (c) Cell centroid velocities at different times upon local activation of 
optoPlexin in MC3T3-E1 cells. Blue line, illumination at 440 nm, n = 21 cells. (d) The 
locally induced retraction (blue) and the distal protrusion (red) after pulses of 
illumination (yellow) of an optoPlexin-expressing cell was illustrated in a morphology 
diagram. The overlapping cell area before and after illumination was labeled in 
green. Based on the centroids of these color-coded regions, θ1 and θ2 were used to 
describe the angles of retraction and protrusion relative to the direction from the 
centroid of the cell at time 0 to the center of illumination, respectively. Similarly, d1 
and d2 indicated their centroid distances to the region of illumination, respectively. 
(e), (f) Angles of retraction and protrusion induced by local activation of optoPlexin in 
MC3T3-E1 cells and (g) standard deviation of their distribution, n = 14 cells. (h) 
Proximity of retractions and protrusions induced by local activation of optoPlexin in 
MC3T3-E1 cells to the region of illumination, n = 14 cells. For a, b, c & h, means ± 
s.e.m are shown, *** p<0.001, * p<0.05, NS, not significant, Student’s t-test. For g, 
*** p<0.001, * p<0.05, NS, not significant, F-test. 
  
 
 80 
 
  
Figure 31. OptoPlexin induces cells to migrate away from the site of activation. (a) 
MC3T3-E1 cell expressing mCherry-optoPlexin was locally illuminated as indicated 
(white circle). The DIC and TIRF images were shown to illustrate the local 
membrane recruitment of mCherry-optoPlexin, and change in direction of 
migration. Scale bar, 10 μm. Asterisk, retraction. Arrowhead, induced protrusion. 
Changes in the direction of migration of the cell is illustrated by the changes in the 
centroid (b) and nucleus (c) of the cell. The change in direction of migration of the 
cenroid appears to be more gradual and precedes that of the nucleus. Blue circle, 
initial region of illumination.  
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Figure 32. Changes in cell motility upon optoPlexin activation. Cell nucleus 
velocities at different times upon local activation of optoPlexin in MC3T3-E1 
cells. Blue line, illumination at 440 nm. n=21 cells, mean ± s.e.m. are shown. *** 
p<0.001, * p<0.05, NS, not significant. 
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Both RhoA and RasGAP pathways are required for CIL 
To determine which pathway(s) downstream of optoPlexin mediates CIL, we 
quantified the changes in protusive areas induced by optoPlexin activation. We 
already showed that the delPBD mutant failed to inhibit protrusion (Figure 29b, 
30a, Supplementary Movie 13). A specific ROCK inhibitor Y-27632 also abrogated 
optoPlexin mediated retractions (Figure 30a), further validating the role of RhoA-
ROCK signaling in Plexin-B1 mediated retractions. In addition, we tracked the 
signaling molecules upstream or downstream of RhoA. We locally activated 
mCherry-optoPlexin in cells coexpressing mVenus-PRG, and found PRG was 
recruited immediately to the spot where optoPlexin accumulated (Figure 33a, 
Movie 15). The line-scan profile of PRG resembled that of optoPlexin very closely 
(Figure 33b), which is consistent with a physical interaction between these two 
proteins. Myosin II regulatory light chain (MyoRLC) is phosphorylated by ROCK 
downstream of RhoA, which leads to its association with actin filaments. We used 
mCherry-MyoRLC in TIRF imaging to track the immobilized myoRLC as an 
indicator of myosin II activation151. Upon local activation of mVenus-optoPlexin, we 
observed accumulation of mCherry-myoRLC at the site of illumination, but with an 
apparent delay (Figure 33c, d, Supplementary Movie 16). Interestingly, the distal 
protrusions induced were associated with substantially decreased myoRLC, 
suggesting a depletion of myosin activity in these nascent protrusions (Figure 33c, 
e). An optoPlexin mutant (optoPlexin-RA) (Figure 21) lacking RasGAP activity also 
failed to induce retraction (Figure 30a, 34, Supplementary Movie 17). The 
response of MC3T3-E1 cells upon local activation of optoPlexin-YF mutant was 
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indistinguishable from that of optoPlexin (Figure 30a, 35, Supplementary Movie 
18). In all cases where retraction was not induced, protusions also failed to form in 
distal regions. Thus both RhoA and RasGAP pathways are required for optoPlexin 
to induce CIL.  
Local activation of optoPlexin repolarizes PIP3 
Phosphoinositides, in particular phosphatidylinositol(3,4,5)P3 (PIP3), are 
extensively involved in regulation of cell polarity and motility152,153. To examine 
whether PIP3 is regulated in migration of MC3T3-E1 cells, we employed the PH 
domain of Akt (PH-Akt) to monitor the spatial distribution of PIP351. Ratiometric 
imaging of mVenus-PH-Akt and a cytosolic mCerulean volume maker were imaged 
using TIRF microscopy and their ratio (mVenus/mCerulean) was used to indicate 
the levels of PIP3 enrichment. Consistent with a role of PIP3 in migration, we 
observed accumulation of PIP3 at the leading edge and low levels in retracting 
areas of migrating MC3T3-E1 cells (Figure 36a, b). Because of the overlapping 
wavelengths between optoPlexin activation and mCerulean excitation, to 
investigate spatial regulation of PIP3 during optoPlexin mediated CIL, we activated 
mCherry-optoPlexin at protrusions first and acquired a pair of mVenus and 
mCerulean images upon induction of distal protrusions. In contrast to an elevated 
PIP3 seen in unperturbed protrusions, a substantial reduction of PIP3 was 
observed in the area of optogenetic illumination. Furthermore, we observed an 
acute accumulation of PH-Akt in the newly formed distal protrusions (Figure 36c, 
d). Neither optoPlexin-delPBD nor optoPlexin-RA induced significant decrease of 
local PIP3 (Figure 36d) upon at least 7.5 minutes of local activation. Thus our data 
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supported the requirement of both RhoA activation and RasGAP activity of Plexin-
B1 in regulating PIP3 in osteoblasts. 
OptoPlexin spatially coordinates Cdc42 activity in CIL 
Small GTPases Rac1 and Cdc42 are potent inducers of actin polymerization 
and migration. Employing Dora-Cdc42 and Dora-Rac1 biosensors154, we observed 
elevated Cdc42 activation at protrusions in migrating MC3T3-E1 cells, whereas 
Rac1 activity was less polarized (Figure 37). To examine how optoPlexin may 
affect Cdc42 and Rac1 activities, we co-expressed mCherry-optoPlexin with a 
Dora-Cdc42 or Dora-Rac1 sensor in MC3T3-E1 cells. We activated optoPlexin 
exclusively in a protrusion where Cdc42 was expected to be active. In order to 
avoid activating optoPlexin globally, we acquired sensor images when distal 
protrusion(s) were induced (Figure 38a, b). We did not detect any active Cdc42 in 
the illuminated and retracting area, suggesting local inhibition of Cdc42 activity 
(Figure 38b, e). In contrast, the new protrusions in distal regions showed marked 
activation of Cdc42. Moreover, a non-binding control sensor exhibited low ratio 
values and minimal variation across the cell (Figure 38c-e), suggesting that the 
Cdc42 polarization was not due to a volume artifact. Using the Dora-Rac1 sensor, 
we found that Rac1 was also activated in the distal protrusion(s), albeit to a 
substantially reduced level (Figure 38e, 39). Thus, our data indicated that spatial 
and temporal activation of Cdc42 and possibly Rac1 may coordinate the opposing 
effects between local and distal regions upon optoPlexin activation.  
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Figure 33. OptoPlexin induces CIL through RhoA mediated pathways.  (a) TIRF 
images showing localized membrane recruitment of mVenus-PRG with mCherry-
optoPlexin in MC3T3-E1 cells upon local illumination. White circle, region of 
illumination. Scale bar, 10 μm. (b) Normalized intensities of mCherry-optoPlexin 
and mVenus-PRG after local illumination in a linescan analysis. Reference line for 
the linescan is shown in the right top panel of (a). (c) TIRF images showing a 
polarized distribution of mCherry-MyoRLC upon local activation of mVenus-
optoPlexin in MC3T3-E1 cells. White circle, region of illumination. Asterisk, 
induced retraction. Arrowhead, induced protrusion. Scale bar = 10 μm. (d) 
Temporal changes in average mCherry-MyoRLC intensity in a 50 μm diameter 
circle around the region of illumination (white circle) in MC3T3-E1 cells upon 
localized activation of mVenus-optoPlexin. Red and green circles indicate t1/2 for 
optoPlexin and RhoA inductions respectively as estimated from Fig. S4b. Blue line, 
illumination at 440 nm. (e) Relative intensities of mCherry-MyoRLC in retractions 
and new protrusions induced by local activation of mVenus-optoPlexin, 
normalized to the whole cell average. For (d) and (e) n = 12 cells, means ± s.e.m. 
*** p<0.001, * p<0.05, NS, not significant, Student’s t-test. 
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Figure 34. RasGAP deficient optoPlexin fails to induce CIL. (a) MC3T3-E1 cells 
expressing mCherry-optoPlexin-RA were locally illuminated as indicated (white 
circle). The DIC and TIRF images were shown to illustrate the morphological 
changes and local membrane recruitment. Scale bar, 10 μm. (b) Kymograph 
showing cell border progression upon local activation of optoPlexin-RA. Reference 
line for the kymograph is shown in white in (a). Scale bar, 10 μm. n ≥ 10. 
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Figure 35. ErbB2 does not mediate optoPlexin-induced cell repolarization. (a) 
MC3T3-E1 cells expressing mCherry-optoPlexin-YF were locally illuminated as 
indicated (white circle). The DIC and TIRF images were shown to illustrate the 
morphological changes and local membrane recruitment. Scale bar, 10 μm. 
Asterisk, retraction. Arrowhead, induced protrusion. (b) Kymograph showing cell 
border progression upon local activation of optoPlexin-YF. Reference line for the 
kymograph is shown in white in (a). Scale bar, 10 μm. (c) Comparison of delay in 
initiation of local retractions on local optoPlexin and optoPlexin-YF activation. n ≥ 
10, means ± s.e.m. *** p<0.001, * p<0.05. NS, not significant. 
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Figure 36. Local activation of optoPlexin repolarizes PIP3.  (a) TIRF images of 
mVenus-PH-Akt and CFP (volume marker) in an MC3T3-E1 cell were processed to 
generate a ratiometric image (mVenus/CFP) that displays the membrane 
enrichment of mVenus-PH-Akt, indicative of PIP3 concentration. Asterisk, 
retraction. Arrowheads, protrusions. Scale bar, 10 μm. (b) PIP3 distribution in 
protrusions and retractions in MC3T3-E1 cells, as measured by membrane 
enrichment mVenus-PH-Akt normalized to the whole cell average, n =9 cells (c) 
TIRF images showing local induction of mCherry-optoPlexin in a MC3T3-E1 cell 
expressing mCherry-optoPlexin, mVenus-PH-Akt and CFP. Upon induction of CIL, 
mVenus and CFP images were obtained and processed to generate ratiometric 
image (d) indicating PIP3 distribution. White circle, region of illumination. Scale 
bar, 10 μm. Asterisk, induced retraction. Arrowhead, induced protrusion. (e) 
Quantification of PIP3  indices in a 50 μm diameter circle centered at the region of 
illumination upon local activation of optoPlexin, optoPlexin-delPBD and 
optoPlexin-RA; and in distal protrusions induced by local activation of optoPlexin, 
normalized to whole cell average, n = 8-12 cells.  For b and e means ± s.e.m. are 
shown. *** p<0.001, * p<0.05, NS, not significant, Student’s t-test. 
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Figure 37. Spatial regulation of Rac1 and Cdc42 in migrating MC3T3-E1 cells.  
Ratiometric  images showing spatial distribution of Rac1 and Cdc42 activities as 
measured using DORA biosensors in migrating MC3T3-E1 cells. Scale bar, 10 
μm.  
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Figure 38. Local activation of optoPlexin spatially coordinates Cdc42 and Rac1 
activities. DIC and TIRF images showing local accumulation and activation of 
mCherry-OptoPlexin in MC3T3-E1 cells co-expressing a Dora-Cdc42 biosensor (a) 
or its non-binding control (c). Upon induction of CIL, a pair of FRET and CFP 
images were acquired using TIRFM and processed to generate a ratio image for 
the Dora-Cdc42 sensor (b) and its non-binding control (d). White circle, region of 
illumination. Scale bar, 10 μm. Asterisk, induced retraction. Arrowhead, induced 
protrusion. (e) Quantificaiton of the spatial distribution of active Cdc42 and Rac1 
in MC3T3-E1 cells after induction of CIL,  n = 9-12 cells, means ± s.e.m. are shown. 
*** p<0.001, * p<0.05, NS not significant, Student’s t-test. 
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Figure 39. OptoPlexin alters Rac1 polarization. DIC and TIRF images showing 
local activation of mCherry-OptoPlexin and induction of CIL in MC3T3-E1 cells 
co-expressing Dora-Rac1 biosensor. Upon induction of CIL, TIRF FRET and CFP 
images were captured and processed to generate ratiometric image 
indicating Dora-Rac1 sensor activity as displayed in pseudo-colour. Blue 
circle, region of illumination. Scale bar, 10 μm.  Asterisk, induced retraction. 
Arrowhead, induced protrusion.  
 
8.0 
1.0 1.0 
2.5 
op
to
Pl
ex
in
 
R
ac
1 
se
ns
or
 
* 
 92 
OptoPlexin redistributes β-Pix to distal regions during CIL 
To understand how optoPlexin may regulate Cdc42 and Rac1, we focused 
on a ubiquitously expressed RhoGEF β-Pix, which activates Cdc42 and Rac1155,156 
and mediates crosstalk between RhoA and Cdc42/Rac1. In migrating MC3T3-E1 
cells, β-Pix is predominantly associated with nascent adhesions and focal 
complexes in protrusions rather than with focal adhesions in stationary or retracting 
areas (Figure 40 a-c). Consistent with previous reports157, inhibition of RhoA-
ROCK signaling using ROCK inhibitor Y-27632 promoted association of β-Pix with 
adhesions (Figure 40d). To examine how optoPlexin may affect β-Pix locally, we 
co-expressed mVenus-Venus-fecmCherry-Paxillin with optoPlexin in MC3T3-E1 
cells and tracked their changes upon optoPlexin activation in separate 
experiments. Upon activating optoPlexin, β-Pix was rapidly depleted in illuminated 
region (Figure 41a, b top panel, 42a, Supplementary Movie 19). This depletion was 
not due to a loss of adhesions as we observed an increase in the intensity of 
paxillin around sites of illumination (Figure 41c, d top panel, 42b, Supplementary 
Movie 20). The opposite changes in β-Pix and paxillin accumulation indicate 
dissociation of β-Pix from the adhesion molecular complex (Figure 41e, 42). The 
decrease of β-Pix around the region of illumination preceded or coincided with the 
initiation of retraction (Figure 41b top panel, 42c). Moreover, we observed a 
concurrent accumulation of β-Pix and nascent adhesions in distal regions where 
new protrusions were produced (Figure 41b, d bottom panels). In support of the 
involvement of RhoA signaling, optoPlexin-delPBD failed to deplete β-Pix locally, 
and addition of ROCK inhibitor Y-27632 also abrogated the effects of optoPlexin 
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on Plexin on β-Pix redistribution (Figure 41f, 43). The presence of exogenous β-Pix 
caused a delay in retraction that was proportional to the level of β-Pix expression 
(Figure 41g), suggesting that a local depletion of β-Pix may be required for the 
initiation of retraction. Taken together, these data revealed a novel mechanism in 
which a redistribution of β-Pix mediated by Plexin-B1-RhoA pathway coordinates 
CIL.   
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Figure 40. Spatial regulation of β-Pix in migrating MC3T3-E1 cells. (a) 
Representative TIRF images showing spatial distribution of mCherry-Paxillin 
and mVenus-β-Pix in a migrating MC3T3-E1 cell. (b) Inset squares at a 
protrusion and a retraction in (a) are magnified, and processed to generate a 
ratiometric image (mVenus-β-Pix/mCherry-Paxillin), which illustrates the 
differences in mVenus-β-Pix and mCherry-Paxillin association withnascent and 
mature adhesions at protrusions and retractions respectively. For (a) and (b) 
scale bar, 5 μm. (c) Normalized ratio of mVenus-β-Pix to mCherry-Paxillin 
signal in migrating MC3T3-E1 cells at retractions and protrusions. (d) Changes 
in mCherry-Paxillin, mVenus-β-Pix and mVenus-β-Pix/mCherry-Paxillin ratio in 
MC3T3-E1 cells on 10 μM Y-27632 ROCK inhibitor treatment, normalized to 
values prior to treatment. n = 7 cells, mean ± s.e.m. *** p<0.001, * p<0.05. 
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Figure 41. OptoPlexin mobilizes and redistributes β-Pix to distal regions. TIRF images showing 
intensity changes of mCherry-optoPlexin and mVenus-β-Pix (a), or mVenus-optoPlexin and 
mCherry-Paxillin (c) in MC3T3-E1 cells upon local illumination. White circle, region of 
illumination. Scale bar, 10 μm. Asterisk, induced retraction. Arrowhead, induced protrusion. 
Inset squares in (a) and (c) are magnified to show temporal changes in mVenus-β-Pix (b) or 
mCherry-Paxillin (d) at induced retractions (b,d, top panels) or protrusions (b, d, bottom panels). 
Scale bar, 2 μm. (e) Quantification of fluorescence intensities of mCherry-Paxillin (n = 10 cells) 
and mVenus-β-Pix (n = 18 cells) in a 50 μm diameter circle centered at the region of illumination 
on local optoPlexin activation in MC3T3-E1 cells. Blue line, illumination at 440 nm. (f) 
Quantification of mVenus-β-Pix depletion in a 50 μm diameter circle centered at the region of 
illumination upon local illumination of MC3T3-E1 cells expressing optoPlexin, delPBD, or 
optoPlexin with addition of 10 μM Y-27632 (n = 10-18 cells). (g) Delay in initiation of retraction 
upon local activation of mCherry-optoPlexin with respect to exogenous β-Pix expression levels in 
MC3T3-E1 cells.  Red circle indicates mean delay in initiation of retraction by local activation of 
mCherry-optoPlexin in MC3T3-E1 cells without exogenous β-Pix expression as measured in Fig. 
3e. R2, Pearson correlation coefficient. (h) Model of Sema4D-Plexin-B1 mediated CIL between 
osteoclasts and osteoblasts. For e & f, means ± s.e.m are shown. *** p<0.001, * p<0.05, NS, not 
significant, Student’s t-test.  
  
 
Figure 42. Sp al and temporal changes in β-Pix and paxillin upon opto lexin activation. (a)
Changes in mVenus-β-Pix in a 50 μ  diam ter circle centered around the region of 
illumination in MC3T3-E1 cells upon local activatio  f mCherry-optoPlexin. Mean ± s.e.m, 
n=14. (b) Changes in mCherry-Paxillin in a 50 μm dia eter circle centered around the 
region of illumination in MC3T3-E1 cells upon local activatio  of mVenus-optoPlexin. Mea  
± s.e.m, n=8 cells. (c) Delay in initiation of mVenus-β-Pix depletion in a 50 μm diameter 
circle centered around the region of illumination, and that of retraction upon local 
activation of mCherry-optoPlexin activation.  *** p<0.001, * p<0.05. 
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Figure 43. β-Pix redistribution by optoPlexin requires RhoA activation. 
Representative TIRF images showing lack of mVenus-β-Pix depletion from the 
region of localized mCherry-optoPlexin-delPBD activation in MC3T3-E1 cells. Blue 
circle, region of illumination. Scale bar, 10 μm. 
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Discussion:  
Semaphorin-Plexin signaling attracts a lot of research interest because of its 
important functions in development and diseases. In vivo semaphorins are often 
present as directional cues for cell migration, and thus experimental perturbations 
with spatial control at the subcellular scale can offer unique insight into their 
signaling mechanisms. One of the technical challenges in spatial control is that 
existing ligand-based methods may not be optimal for localized stimulation. Here 
we describe a novel approach to precisely control the location and time of Plexin-
B1 activation with light. We validated this new optogenetic reagent by tracking its 
binding with two known interacting RhoGEFs, PRG and LARG, and by visualizing 
its activation of RhoA. We named the new tool optoPlexin, following the naming 
convention of many optogentic reagents developed in recent years158–161. To our 
knowledge, optoPlexin is the first optogenetic tool for the receptors of repulsive 
guidance molecules.  
The optogenetic module Cry2 has two independent134 modes of action, i.e. 
inducible translocation mediated by CIB1132 and homo-oligomerization133, which 
benefitted optoPlexin design to reduce dark background. We found that mere 
oligomerization (by omitting CIB-CAAX) is not sufficient for inducing binding of 
PRG, a GEF for RhoA (Figure 26d,e) or RhoA activation (Figure 26g). It is likely 
that additional factors such as Rnd1 or Rac1 on the plasma membrane may 
participate in recruiting PRG63,69,70. Additionally, the slow off-rate of Cry2-CIB1 
binding helped to maintain the Plexin-RhoGEF complex locally, mimicking 
sustained contact between osteoblasts and osteoclasts. Using optoPlexin, we 
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demonstrated spatial modulation of different regulators of cell migration to 
understand the signaling mechanism involved in CIL between osteoclasts and 
osteoblasts. Since plexins share high sequence homology in their intracellular 
regions62, optoPlexin design should be extendable to other plexins as well.  
Upon Sema4D stimulation ErbB2 associates with and is transactivated by 
Plexin-B1 and regulates RhoA activation through Phospholipase C-γ(PLC-γ)86,149. 
Given that the interaction with ErbB2 is mediated by the extracellular domain of 
Plexin-B1, it is unlikely that optoPlexin can associate with or activate ErbB2, which 
could be a limitation of optoPlexin. However, clustering of the cytosolic domain of 
Plexin-B1 on the membrane was shown to be sufficient for RhoA activation141. Our 
results also demonstrated that optoPlexin sufficiently recruits RhoGEF and 
activates RhoA. Mutations designed to abrogate PLC-γ association (optoPlexin-
YF) did not affect RhoGEF recruitment, RhoA activation or the repulsion phenotype 
induced by optoPlexin. It is possible that ErbB2 mediated tyrosine phosphorylation 
of Plexin-B1 and consequent association with PLC-γ promotes clustering of the 
endogenous protein, which is compensated by light induced clustering of 
optoPlexin. 
 In interrogating Plexin-B1 signaling, we probed the RhoA-ROCK-Myosin 
pathway, and observed accumulation of MyoRLC and maturation of nascent 
adhesions in the protrusions where optoPlexin was activated. Local activation of 
optoPlexin repolarized active Cdc42 and active Rac1 away from the retracting 
area to new distal protrusions. We attribute these effects to mobilization and a 
redistribution of β-Pix. Crosstalk among Rho GTPases are known to facilitate cell 
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migration and polarity55. β-Pix is one of the molecules that mediate cross-talk 
between RhoA and Cdc42 or Rac1. Myosin II-mediated contractility, downstream 
of RhoA/ROCK signaling, has been shown to induce dissociation of β-Pix from 
adhesions and decrease Rac1 activation157. While we identified RhoA/ROCK 
activity being critical for local depletion of β-Pix, the exact molecular mechanism 
by which β-Pix is regulated demands further investigation. Our observations of 
opposite repolarization of MyoRLC and adhesion maturation compared to β-Pix 
are consistent with a model of mechanical regulation, although we cannot rule 
out a role of ROCK mediated phosphorylation of β-Pix155,162 in its redistribution. 
Importantly, localized Plexin-B1 signaling did not simply deplete β-Pix, but 
induced redistribution to distal regions and activated Cdc42 and Rac1 to promote 
new protrusions. While we also observed repolarization of PIP3, the underlying 
signaling mechanism remains to be explored. Plexin-B1 may inhibit PIP3 by 
activating Phosphatase and tensin homolog (PTEN) via its RasGAP domain163. 
RhoA activation by Plexin-B1 may also activate PTEN and SH2 domain 
containing inositol 5’-phosphatase 2 (SHIP2)57,164. In other studies, Plexin-B1 has 
been reported to promote PIP3 production through activation of phosphoinositide 
3-kinases (PI3Ks)90,165. R-Ras is another important target that regulates CIL, as 
evident from the inability of optoPlexin-RA to induce CIL or PIP3 redistribution. All 
plexins contain a RasGAP domain16,56 and other repulsive guidance molecules 
such as ephrins also inhibit R-Ras65,66, suggesting that R-Ras may play a critical 
role in mediating repulsion between cells. 
Optogentic approach offers spatial and temporal control in initiating 
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signaling pathways in subcellular regions. This is particularly lucrative in studying 
CIL since the underlying signaling is initiated specifically at the site of cell-cell 
contact. Precise activation of optoPlexin in leading protrusions steered MC3T3-
E1 cells away in a manner reminiscent of osteoclast-mediated CIL and followed 
similar timelines of retractions and protrusions (Figure 41h). While CIL has been 
proposed to transiently promote cell motility166, both osteoclasts and localized 
optoPlexin stimulation induced CIL without affecting the overall motility of 
MC3T3-E1 cells (Figure 13b, 30c, 32). Previous studies have reported formation 
of transient cadherin-mediated cell-cell adhesions that generate mechanical 
tension across cells undergoing CIL47,56,59,167,168. We observed a sustained 
contact between osteoclasts and osteoblastic cells before separation 
(Supplementary Movie 2, 3, 5), which may potentially be critical for Plexin-B1 
clustering. Whether osteoblasts and osteoclasts form any cadherin-mediated 
inter-cellular adhesions and their role in heterotypic CIL remains to be 
investigated. Our experiments with optoPlexin cannot decipher the nature and 
duration of such cell-cell contact. Nevertheless, we observed  cellular response 
comparable to CIL induced by osteoclasts with similar kinetics (Figure 41h), 
suggesting that localized activation of Plexin-B1 was sufficient to generate similar 
behavior. Furthermore, our observations on spatial redistribution of PIP3, active 
Cdc42 and active Rac1 suggest that although different signaling mechanisms 
may initiate homotypic and heterotypic CIL, their effects converge to induce 
similar spatial changes in factors that regulate cell migration.  
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In recent years, repulsion between cells has been implicated in many 
physiological and pathological processes37. Our data demonstrate CIL between 
osteoblasts and osteoclast. In the bone microenvironment, resorption by 
osteoclasts is followed by deposition of matrix by osteoblasts. Osteoclasts are 
generally thought to attract osteoblasts to the site of resorption through release of 
chemoattractants8,9,144,145. However, a simple chemotaxis model does not explain 
spatial segregation of osteoclasts and osteoblasts on the bone surface15, which is 
consistent with their opposing functions. Our observation of CIL between 
osteoclasts and osteoblasts explains the spatial segregation between osteoblasts 
and osteoclasts15,58. Additionally, loss of Sema4D has been reported to impact 
bone resorption119. Whether osteoclasts utilize similar signaling mechanisms to 
repel osteoblastic bone lining cells and gain access to the bone matrix to initiate 
resorption remains to be investigated.  A combination of CIL and chemotaxis might 
facilitate osteoblasts occupying sites of resorption only after the short-lived 
osteoclasts disappear. Considering the multitude of coupling factors between 
osteoclasts and osteoblasts, further research is necessary to gain a complete 
understanding of how osteoclasts modulate osteoblast migration and function.  
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Materials and methods 
Cell culture and transfection  Primary calvarial osteoblasts (POB) were obtained 
as described previously169 from two month old inbred C57BL/6 male mice. Briefly, 
calvariae from 5-6 neonatal mice were minced, washed with Phosphate-buffered 
saline (PBS) and digested with 0.5 mg/ml collagenase P (Roche Diagnostics, 
Indianapolis, IN) and 0.5 mg/ml Trypsin/EDTA in PBS at 37°C four times for 10 
minutes each and a final digest for 90 minutes. Cells isolated from digests 2-5 
were combined and plated at a cell density of 4 × 104 cells/well in 6 well dishes for 
imaging experiments. For coculture experiments, POBs were lifted at day 5-7 after 
isolation. For real-time quantitative PCR, MC3T3-E1 and POBs were plated at 
5X104 cells /well in 6-well dishes and cultured in osteoblast differentiation media for 
7 or 14 days. Osteoblast differentiation medium consisted of basic medium plus 50 
µg/ml phosphoascorbate (Wako Pure Chemical Industry, Osaka, Japan). Media 
were changed every 3 days. 5 mM of β-glycerophosphate (Sigma-Aldrich, Saint-
Louis, MO) was added on day 7 of these cultures. Bone marrow macrophages 
(BMMs) were made as described previously169  following the protocols of R. Faccio 
(www.orthoresearch.wustl.edu/content/Laboratories/2978/Roberta-Faccio/Faccio-
Lab/Protocols.aspx) from 5-6 two month old inbred C57BL/6 and outbred CD1 
male mice. For osteoclastic differentiation, recombinant mouse macrophage-
colony stimulating factor (M-CSF) and receptor activator of nuclear factor κ B 
ligand (RANKL) were purchased from R & D systems (Minneapolis, MN, USA). 
BMMs were plated at 6X104 cells/well in 12-well dishes in basic medium plus 30 
ng/ml M-CSF with or without RANKL (30 ng/ml) for 3 days. Vehicle for RANKL and 
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M-CSF was 0.1% bovine serum albumin (BSA) in phosphate buffered saline 
(PBS). 
All studies were conducted in accordance to the approved protocols by the 
Institutional Animal Care and Use Committee of the University of Connecticut 
Health Center.  
COS-7 and MC3T3-E1 cells were obtained from American Type Culture 
Collection (ATCC) and were cultured in DMEM and α-MEM (Lonza, Basel, 
Switzerland) basal media respectively, and were passaged every third day of 
culture. For optimal growth, the media were supplemented with 10% (v/v) FBS 
(Gibco, Billings, MO) and Penicillin/Streptomycin (Lonza), and the cells were 
maintained under standard cell culture conditions (37°C and 5% CO2). The cell 
lines were regularly checked for mycoplasma contamination. FuGENE 6 reagent 
(Promega, Madison, WI) was used for transient transfections according to 
manufacturer’s instructions. Lentiviral transductions for shRNA and CRISPR-
Cas9 approaches were performed as previously described.   
DNA plasmids  pLKO.1 puro vector (Addgene plasmid # 8453) was a gift from Dr. 
Bob Weinberg. lentiGuide-Puro (Addgene plasmid # 52963) and lentiCas9-Blast 
(Addgene plasmid # 52962) were gifts from Dr. Feng Zhang (Massachusetts 
Institute of Technology, Cambridge).  The farnesylated CIB (CIB-CAAX) and full-
length Cry2 expression plasmids (same as addgene plasmids 28240 and 26871 
respectively) were gifts from Dr. Chandra Tucker (University of Colorado, Denver). 
The source cDNAs of mouse Plexin-B1, Plexin-B1-RA, and Plexin-B1-delPBD (Fig. 
S1) were from Dr. Hiroshi Takayanagi (Tokyo Medical and Dental University, 
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Japan). The cDNAs of PRG and LARG were from Dr. Keith Burridge (University of 
North Carolina at Chapel Hill),   of PRG and LHordijk (University of Amsterdam, the 
Netherlands), myosin regulatory light chain (MRLC) from Dr. Rex Chisholm 
(Northwestern University), and PH-Akt from Dr. Craig Montel (University of 
California,Santa Barbara). These constructs were initially subcloned into the 
pTriEx-4 vector (Novagen) using polymerase chain reaction (PCR) and restriction 
digestion. Cry2 was positioned at the N-terminus and Plexin-B1 at the C-terminus 
to minimize interference with PRG and LARG. As indicated in the results and figure 
legends, tags of compatible fluorescent proteins including mCerulean, mVenus and 
mCherry were appended to facilitate detection. Unless specified otherwise, the 
termini of tagging were positioned as in the orders they were written. Additional 
point mutations in the Cry2, D387A and D393A, were generated using overlapping 
PCR. The open reading frames of all DNA plasmids were verified by DNA 
sequencing. 
Co-culture migration assay Cell culture inserts (Ibidi, Germany) were used 
according to manufacturer’s instructions. Briefly, the culture inserts were placed 
on tissue culture dishes and BMMs were cultured and differentiated into 
osteoclasts inside one of the insert chambers. Upon appearance of 
multinucleated osteoclasts, osteoblasts or MC3T3-E1 cells were added to the 
empty adjacent chamber. After 5-6 hours of incubation allowing the cells to 
adhere to the tissue culture dish, the inserts were gently lifted using tweezers 
enabling the cells to migrate towards the osteoclasts. Delay in retraction and 
protrusions upon contact were determined by visual inspection. Initiation of 
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retraction was identified as the time point when a protrusion in contact with 
osteoclasts began to contract. Initiation of protrusions was identified as the time 
point of formation of the persistent protrusions that enabled the cell to migrate 
away from the site of contact. Cell velocities were computed by measuring the 
displacement of the cell nuclei. 
Quantification of CIL Whether a protrusion collapsed at the site of cell-cell 
contact was determined by visual inspection using time lapse images within 30 
minutes after contact. Previous studies have quantified CIL by measuring spatial 
separation between cells undergoing CIL42,47,59. Since osteoclasts are large cells 
with multiple nuclei, we determined the spatial separation between osteoclasts 
and osteoblasts by computing the difference in distances between the 
osteoblastic nucleus and the site of contact at the time of and 40 minutes after 
contact. Positive and negative values respectively indicate spatial separation or 
lack of it. Changes in direction of migration of osteoblasts after contact were 
assessed by measuring contact acceleration indices (Cx) using vector analyses 
as described previously42–44. Briefly, the displacement of a migrating osteoblast 
for 40 min before contact (vector A) and 40 min after contact (vector B) were 
determined by tracking the nuclei. The Cx component of the vector (B-A) is a 
measure of how much the cell has deviated from its original trajectory (vector A’) 
in the migration axis after contact (Figure 12h). Cx values for MC3T3-E1 cells 
that did not come in contact with osteoclasts were also determined for 40 minute 
intervals. Positive and negative values of Cx respectively indicate persistence 
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and reversal of direction of motion. In the absence of CIL, Cx approaches zero, 
whereas higher magnitudes indicate significant deviation from expected path.  
Real-time quantitative PCR  Total RNA was extracted using Trizol (Invitrogen) 
following manufacturer’s instructions. 4 μg of total RNA was DNase treated 
(Ambion Inc., Austin, TX) and converted to cDNA by the High Capacity cDNA 
Archive Kit (Applied Biosystems, Foster City, CA). PCR was performed in 96-well 
plates. Assays-on-Demand Gene Expression Taqman primers (Applied 
Biosystems) were used for PCR (Mm99999915_g1 for Gapdh; Mm00443147_m1 
for Sema4d; Mm00555359_m1 for Plxnb1). Gapdh served as endogenous 
control. All primers were checked for equal efficiency over a range of target gene 
concentrations. Each sample was amplified in duplicate.  PCR reaction mixture 
was run in Applied Biosystems Prism 7300 Sequence Detection System 
instrument utilizing universal thermal cycling parameters. Data analysis was done 
using relative quantification (RQ, ΔΔCt) or the relative standard curve method. 
As per manufacturer’s recommendation, any cycle threshold (Ct) values obtained 
below 33 were considered undetectable for that particular target gene. 
Western blot analysis  MC3T3-E1 and POBs prior and after addition of β-
glycerophosphate were washed three times with phosphate-buffered saline, and 
lysed on ice in a buffer containing 1% Triton X-100, 50 mM monobasic sodium 
phosphate (pH 7.4), 150 mM NaCl, 5 mM EDTA and HaltTM Protease inhibitor 
cocktail (Thermo Scientific, Rockford, IL, USA). The cell lysates were fractionated 
using 4-12% NuPAGE gels (Invitrogen), immobilized on to PVDF membranes 
(Millipore), followed by immunoblotting using anti-Plexin-B1 monoclonal antibody 
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(A-8, Santa Cruz Biotechnology, Dallas, TX, USA) or anti-alpha-tubulin 
monoclonal antibody (DM1A, Cedarlane laboratories, Burlington, Ontario, 
Canada) and horseradish peroxidase-coupled secondary antibody (Millipore, 
Germany). Enhanced chemiluminescence detection (Pierce, Waltham, MA, USA) 
and autoradiography were used to detect the signals. For detection of Sema4D-
Fc horseradish peroxidase-coupled Protein-A was used. The blot images were 
cropped to show relevant bands. For Figure 12c, the uncropped scan is shown in 
Figure 44. 
RNAi approaches and CRISPR-Cas9 mediated Plexin-B1 knock out 
siGENOME non-targeting (D-001206-13-05) and Plexin-B1 (M-040982-01-0005) 
siRNA pools (GE Dharmacon, Colorado, USA) were used according to 
manufacturer’s instructions. 
shRNA target sequences for luciferase (Luc, TRCN0000072254 )  and 
Plexin-B1 (sh1 - TRCN0000078913,  sh2 - TRCN0000078917 and sh3 - 
TRCN0000078916) were identified using Broad Institute Genetic Perturbation 
Platform web portal (http://broadinstitute.org) and were cloned into pLKO.1 puro 
vector.   
To identify target sites for CRSPR-Cas9 mediated knock-out, the genetic 
sequence of Plexin-B1 was obtained from UCSC genome browser 
(http://genome.ucsc.edu) using the mouse assembly GRCm38/mm10 
(December, 2011). The gene encoding Plexin-B1 has 38 exons, with the start 
codon located within the third exon. Two sgRNAs were designed flanking the 
start codon (Figure 14f,Table 1) using CRISPR design tool by Zhang lab 
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(http://crispr.mit.edu) so that Cas9 mediated cleavage was expected to delete a 
100 bp region including the start codon. The sgRNAs were cloned into 
lentiGuide-Puro vector68. Cas9 and the sgRNAs were stably expressed in 
MC3T3-E1 cells using lentiviral transduction. Genomic DNA from 24 clones of 
the transduced MC3T3-E1 cells were extracted using Quick-gDNATM kit (Zymo 
Research, Irvine, CA, USA) as per manufacturer’s instructions.  Upon PCR 
screening we identified two clones that showed deletion at the expected site 
(Figure 14g, Table 1). DNA sequencing validated the loss of Plexin-B1 start 
codon in both of these clones. Loss of Plexin-B1 expression was further 
confirmed using western blot (Figure 12d). 
Immobilization of Sema4D-Fc and IgG1 on silica beads Sema4D-Fc and 
hIgG1 were immobilized on 5 μm diameter Silica Bind-ITTM pre-activated 
microspheres (Catalog # SB06N) from Bangs Laboratories (Fishers, IN, USA) by 
following the manufacturer’s instructions with minor modifications. Briefly, 50 μl of 
the 2.5% bead suspension was centrifuged at 1000 X G for 5 minutes. The 
supernatant was removed and the beads were washed thrice in 100 μl coupling 
buffer (50 mM MES buffer, pH 5.2). After the final wash, the supernatant was 
removed and 25 μl coupling buffer. 25 μl of Sema4D or hIgG1 solution (0.1 
μg/ml) were added to the bead suspension and incubated for 2 hours at 4 ̊C for 2 
hours on a rotator. The suspensions were centrifuged, the supernatant was 
removed and the beads were washed thrice in 100 μl storage solution (150 mM 
NaCl, pH 7.0). After the final wash, the beads were resuspended in 50 μl storage 
solution and this suspension was used for further experiments. To assess the 
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Figure 44. Full blot for Figure 12c. 
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amount of Sema4D immobilized on the beads, western blot was performed under 
non-reducing conditions. The samples 1X and 1/10X dilutions were equivalent to 
25 μl and 2.5 μl of the bead suspension. From the western blot (Supplementary 
Figure 20d, e) we estimated that 80.5 ng Sema4D-Fc was present in the 1/10X 
sample. The density of the beads as provided by the manufacturer is 2g/cm3. 
Assuming no loss of beads or Sema4D-Fc during the sample preparation and 
assuming perfectly spherical beads, we calculated that the average number of 
Sema4D-Fc molecules bound to each silica bead was around 1000. Assuming a 
hemispheric contact (Figure 20f), each bead would provide 500 Sema4D-Fc 
molecules to come in contact with the cells. Furthermore, an even distribution of 
Sema4D-Fc is equivalent to a surface density of 12.73 molecules/μm2, which 
amounts to a distance of 280 nm between each molecule (Figure 20g). It is 
possible that by using a significantly higher surface density of Sema4D-Fc, or 
enabling diffusion of Sema4D-Fc on such beads by using lipid layers may solve 
this problem; however such approaches would still not allow sufficient spatial and 
temporal control since it is difficult to manipulate the specific time and location of 
contact between cells and the beads. 
Imaging setup.  All time-lapse imaging were performed on a customized Nikon 
Ti-E inverted microscope. Phase contrast images for osteoclast co-culture 
experiments were captured using a 10x objective (NA 0.30) and Andor Neo 5.5 
sCMOS camera. Wide field fluorescence imaging was performed using 40x oil 
objective (NA 1.30) using LED sources for excitations at 438, 513 and 575 nm 
(CoolLED) for imaging mCerulean, mVenus, and mCherry respectively.  TIRF 
 112 
imaging was performed using a 60x oil TIRF objective (NA 1.49). The 
microscope was modified with a “stage-up” design which enables an insertion of 
two independent, motorized dichroic mirrors/filter cubes in the microscope infinity 
space. A dichroic mirror in the bottom cube was used to reflect excitation laser 
lines at 442, 514, 594 nm for imaging of mCerulean, mVenus, and mCherry 
respectively. The laser lines were lunched from a fiber-coupled LMM5 system 
(Andor) equipped with an acousto-optic tunable filter (AOTF) for shutter and 
intensity control. Another dichroic mirror (495LP) in the top cube was used to 
bring in optogenetic illumination originated from a LED source at 440 nm 
(CoolLED). The 495LP mirror permitted immediate acquisition of mVenus or 
mCherry after optogenetic illumination. Alternatively, the top mirror can be 
rotated out to a blank position for Patterned illumination was generated using a 
commercial digital mirror device (Mosaic, Andor). The fluorescent emission was 
captured with an EMCCD camera (iXon Ultra, Andor). Metamorph software was 
used to control the imaging set up. Live cell imaging was performed at 37°C in a 
heated chamber (Bioptechs) with humidified 5% CO2 supply. Vitamin and phenol 
red-free media (US Biological) supplemented with 2% FBS were used in imaging 
to reduce background and photobleaching.  
Membrane recruitment assay  COS-7 or MC3T3-E1 cells were transiently 
transfected with mVenus- or mCherry-optoPlexin along with CIB-CAAX. The 
recruitment of optoPlexin to the plasma membrane was induced with a short pulse 
(50 ms) 440 nm illumination at 10 s intervals, shortly (typically 10-15 frames) after 
acquisition of base lines of fluorescent intensities. For localized activation, a 5 μa-
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diameter circular region near the cell periphery was chosen for each cell. TIRF 
imaging of mVenus and/or mCherry channel was used to gauge the amount of 
optoPlexin that became excitable by the evanescent wave (~200 nm from the 
coverslip surface) presumably due to association with the plasma membrane. 
Because a robust translocation of optoPlexin could be induced in the assay (Fig. 
1c), proteins associated with optoPlexin, labeled with different fluorescent proteins 
for example, mVenus-PRG and mCherry-optoPlexin for example, may also 
‘precipitate’ into the TIRF imaging plane due to association. After conducting 
background subtraction using the mean fluorescence intensities of cell-free 
regions, the fluorescence intensities after 10 blue light pulses were normalized to 
that before blue light illumination, and the changes were used to estimate the 
recruitment of optoPlexin and its associated proteins to the plasma membrane. 
The results of membrane recruitment assay were quantified as follows, 
𝑅" = ∆𝐹 𝐹& (𝑚𝑉𝑒𝑛𝑢𝑠)∆𝐹 𝐹& (𝑚𝐶ℎ𝑒𝑟𝑟𝑦) 
where RC = relative co-recruitment and F = fluorescence intensity. 
To minimize effects of noise in measurement of binding, only cells with at least 
30% fractional increase in optoPlexin signal were considered.  
Quantification of optoPlexin clustering  The local variance of fluorescence 
intensities was used to estimate the extent of molecular clustering of optoPlexin 
and its associated proteins. Briefly, TIRF imaging was used to sample the basal 
focal plane of cell, thereby rejecting most of the out-of-focus fluorescence. The raw 
images were first background subtracted using cell-free regions. To eliminate 
effects of changes in cell topology on changes in variance of fluorescence 
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intensities, a ratio image was then calculated using the original image divided by a 
processed one, which was passed through an empirically determined 5x5 median 
filter. Clustering index was defined as the fractional changes in standard deviation 
of the ratiometric image (Figure 25). 
Analysis of cell repolarization Fluorescence images of MC3T3-E1 cells 
expressing optoPlexin (or its mutants) were thresholded based on intensity to 
produce binary images. Cell velocity at each frame was measured by tracking the 
displacement of the centroids of these binary images, and average of such 
velocities was used to assess the cell velocity. Changes in cell shape were 
identified by subtracting the binary images in a time series from the image at time 
0. Pixels of areas in positive values were identified as protrusions. Conversely 
ones in negative values were identified as retractions. Areas where the images 
overlapped since time 0 were designated as neutral regions. An arbitrary floor was 
added to the image to display these regions in color: red for protrusion, blue for 
retractions and green for regions occupied by the cell at both time points, whereas 
cell free regions were shown in white. The region of blue light illumination is shown 
in yellow (Figure 30d). Only regions exceeding 50 pixels (3.52 μm2) were 
considered in the quantification of protrusions and retractions, and only regions 
that were converted from protrusions to retractions were used to measure 
induction of retractions by optoPlexin.  
 To measure the angle of retraction (θ1) or protrusion (θ2) with respect to the 
region of illumination, a straight line joining the centroid of the cell at time 0 was 
used as the horizontal axis. The angle between the straight line joining the centroid 
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of protrusions (or retractions) and the centroid of the cell at time 0 and the 
horizontal axis was defined as the angle of protrusion (or retraction). The proximity 
of retraction (d1) and protrusion (d2) to the region of illumination was measured by 
the linear distance between the centroid of protrusion (or retraction) and the 
centroid of the region of illumination. Delay in initiation of retraction was 
determined by identifying the time point when the cell area in a 50 μm diameter 
circle centered around the region of illumination (as defined for Figure 30d) began 
to contract. Metamorph (Molecular Devices, Sunnyvale, CA) and Matlab 
(Mathworks, Natick, MA) softwares were used for image processing and data 
analyses. 
Imaging and analysis of FRET sensors  For FRET imaging, donor (mCerulean) 
images were captured sequentially after the FRET (mVenus) image. The Dora-
RhoA sensor uses an intra-molecular effector fragment derived from the RhoA 
effector Protein Kinase N (PKN) to detect the nucleotide states (GDP or GTP) of 
RhoA. Upon GTP-loading or activation of RhoA, Dora-RhoA interacts with the 
effector fragment and adopts a closed conformation. The conformational change 
leads to an increase of FRET signal, the extent of which is quantifiable using the 
ratio of FRET/CFP. For RhoA sensor imaging in MC3T3-E1 cells upon Sema4D-Fc 
or hIgG1 treatment mCerulean and FRET images were acquired every minute. For 
RhoA sensor imaging in COS-7 cells on optoPlexin activation, sequential images 
of mCherry, mCerulean and FRET images were acquired every 10 s using TIRF 
excitation with 594 nm and 442 nm lasers. Since the excitation wavelength for CFP 
and FRET was sufficient to activate Cry2 recruitment, no additional blue light 
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illumination was employed. Ratiometric images of FRET and mCerulean were 
generated and changes in the average intensity of these ratiometric images were 
used to measure changes in RhoA activity. The first image in each of these time 
series was used for baseline measurement of RhoA activity before optoPlexin 
activation. Changes in ratiometric measurements for a binding deficient RhoA 
control sensor in response to mCherry tagged Cry2 recruitment was used to 
correct for optical artifacts of mCherry and Cry2 recruitment to the TIRF plane.  
DORA-Rac1 and DORA-Cdc42 sensors share a similar design as the Dora-RhoA 
sensor except using a Cdc42/Rac interactive binding (CRIB) domain of p21-
activated kinase (PAK) as the binding domain. The non-binding control Cdc42 
sensor control harbours a mutated (H83,86D) effector domain in Dora-Cdc42 and 
does not alter FRET in response to activation. For Cdc42 sensor, Cdc42 control 
sensor and Rac1 sensor imaging in MC3T3-E1 cells, optoPlexin was locally 
activated using the Mosaic illumination system as mentioned above until we 
observed local retraction and distal protrusions, at which point the time lapse 
imaging was ended and FRET and mCerulean images were obtained 
immediately afterwards. Ratiometric images from each of these FRET and 
mCerulean image pairs were processed as described previously69 
and used to visualize the spatial distribution of Rac1 and Cdc42 activities in 
individual cells.  
Statistical analyses Microsoft Excel and Matlab were used for statistical analyses. 
Sample sizes for different experiments were chosen based on the commonly used 
range in the field without conducting any statistical power analysis. Normal 
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probability plot function of Matlab was utilized to confirm normal distribution of the 
data. Similarity of variance across all the groups (or before and after stimulation) 
being compared were tested using F-test in Matlab. For RT-PCR data, one way 
ANOVA was performed using Sigmaplot 11.0 (Systat Inc., Chicago, IL). Sample 
means and standard error of mean was calculated and shown on the graphs. P 
values were obtained from one-tailed Students t-test.  
Data availability: All relevant data are available in the article and the 
supplementary information, or upon request from the authors.  
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Chapter III 
Molecular mechanisms of Plexin-B-mediated activation of PDZ-RhoGEF 
and LARG  
 119 
Introduction: As described in Chapter I and II, B-family plexins activate 
RhoA through two PDZ-domain containing RhoGEFs, PRG and LARG. These 
two RhoGEFs, along with p115, share a regulator of G protein signaling (RGS)-
like domain and are classified as RGS-RhoGEFs172 (Figure 45). Although it is 
largely understood how RGS-RhoGEFs are activated by Ga12/13 of heterotrimeric 
G proteins--activated Gα12/13 binds with the RGS domain and stimulates GEF 
activity173,174; how the B family of plexins activate PRG and LARG remains 
elusive. It is thought that Plexin-B1 interacts with PRG or LARG solely via its C-
terminal PDZ-binding motif (PBD). However, the PBD-PDZ interaction has been 
proposed to be constitutive and thus cannot explain how the RhoGEF activity is 
regulated downstream of Plexin. Previous studies have shown that Rnd1 binding 
to the RBD of Plexin promotes PRG recruitment and RhoA activation69, 
suggesting that 1) an additional interaction(s) may exist between Plexin-B1 and 
PRG and 2) such an interaction may involve or be regulated by the RBD of 
Plexin. Here, I will discuss some results from ongoing investigations into these 
molecular mechanisms.  My data demonstrate that Plexin-B1 RBD acts as an 
autoinhibitory domain in PRG recruitment: deletion or mutation of the RBD can 
relieve the inhibition. Furthermore, we identify the RGS domain of PRG to play a 
critical role in Plexin-B1 binding. Our data sheds new light into the mechanism of 
Rac1 regulation of Plexin-B1 signaling and identifies an unexpected role of the 
RGS domain in PRG binding to Plexin-B1. 
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Results: As discussed in Chapter II, I had developed an optogenetic tool named 
optoPlexin to initiate Plexin-B1 signaling upon blue light illumination, which 
efficiently recruited PRG and LARG to the plasma membrane. We utilized co-
recruitment of PRG by optoPlexin to investigate how Rac1 might regulate PRG 
recruitment by Plexin-B1 (Figure 46). Consistent with the critical role of PBD-PDZ 
interaction, we had observed that an optoPlexin mutant lacking the PBD 
(optoPlexin-delPBD) failed to recruit PRG. Another optoPlexin mutant lacking 
RasGAP activity (optoPlexin-RA) efficiently recruited PRG, suggesting that 
RasGAP activity may not indirectly affect PRG recruitment.  
GTPase binding to Plexin-B1-RBD is critical for RasGAP activity and has 
been reported to promote PRG recruitment and RhoA activation69,63. To test 
whether GTP-loaded Rac1 regulates PRG recruitment by optoPlexin, we co-
expressed a constitutively active mutant of Rac1 (caRac1) tethered to mCerulean 
with optoPlexin and PRG or LARG. Co-expression of caRac1 significantly 
increased recruitment of PRG and LARG by optoPlexin (Figure 47a, b). 
Illuminating photoactivatable Rac1 (paRac1) or plasma-membrane recruitment of 
Cry2-caRac1 did not recruit PRG to the membrane (Figure 47c). Our 
observations indicate that the increased PRG recruitment was not due to direct 
association between caRac1 and PRG. These data suggest that Rac1 binding to 
Plexin-B1-RBD promotes its interaction with PRG. GTP-Rac1 binds to Plexin-B1-
RBD and to investigate the role of Plexin-B1 RBD in PRG recruitment, we utilized 
a previously described mutation in the RBD domain (optoPlexin-GGA, figure 21) 
that is known to destabilize it and abrogate Rac1 binding as well as RasGAP 
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activity62,63,175. Despite the presence of the C-terminal PBD, optoPlexin-GGA 
failed to recruit PRG. This defect was not rescued by co-expression of caRac1 
(Figure 48a), further excluding the possibility that caRac1 may independently 
recruit PRG. We further investigated the role of RBD by utilizing an oncogenic 
mutation in the RBD (OptoPlexin-L1799F, figure 21) that was detected in solid 
tumours176,177. The L1799F mutation increases the RBD stability, abrogates Rac1 
binding, but has no impact on RasGAP function of Plexin-B1176. OptoPlexin-
L1799F recruited PRG very efficiently, at levels comparable to optoPlexin with 
co-expression of caRac1. Co-expression of caRac1 with optoPlexin-L1799F did 
not further promote recruitment (Figure 48a). These opposite effects of GGA and 
L1799F mutants on PRG recruitment prompted us to speculate that these two 
mutants mimic an off and on state of a regulatory switch respectively. We 
hypothesized that either the GTPase-bound RBD provided additional binding 
sites between Plexin-B1 and PRG, or that it inhibited binding between Plexin-B1 
and PRG, with the inhibition relieved upon GTPase binding. To test these two 
scenarios, we designed a mutant with deletion of the RBD (optoPlexin-delRBD, 
figure 21), speculating that lack of PRG recruitment would support a model of 
RBD providing additional binding sites, whereas efficient recruitment would 
support the second model. OptoPlexin-delRBD recruited PRG at levels 
comparable to WT . Further deletion of a short proline rich region in OptoPlexin-
delRBD (optoPlexin-delRBD-PRR, figure 21) did not affect PRG recruitment 
(Figure 48b). 
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Recently, an additional binding site for GTP-Rac1 on Plexin-B1 has been 
identified, which if mutated disrupts Rac1 binding as well as RasGAP activity71. 
GTPase binding to this secondary site has been proposed to be regulated by the 
Plexin-B1 juxtamembrane helix, which facilitates a trimeric Plexin-B1-GTPase 
complex upon Sema4D binding. To test whether the juxtamembrane region of 
Plexin-B1 could regulate PRG recruitment through the GTPase binding site, we 
deleted the juxtamembrane helix in an optoPlexin mutant (optoPlexin-delN, figure 
21). OptoPlexin-delN showed neither any defects nor any improvements in PRG 
recruitment when compared to WT (Figure 48b). It is possible that optoPlexin 
does not undergo the juxtamembrane helix dependent trimerization unlike 
endogenous Plexin-B1; or that even if present, Cry2 mediated clustering 
overshadows any effects such trimeric conformation may have on PRG 
recruitment. Regardless, our observations indicate that the juxtamembrane helix 
of Plexin-B1 was not critical for PRG recruitment. Furthermore, this indicates that 
the RBD predominantly mediates the effects of GTPase binding to Plexin-B1 on 
PRG recruitment. 
Plexin-B1 is thought to recruit PRG through a constitutive interaction 
between the PBD in Plexin and PDZ domain in PRG68. To examine the 
importance of the PDZ-PBD interaction, previously we have shown that 
optoPlexin-delPBD failed to recruit PRG or activate RhoA (Figure 26c). 
Conversely, we introduced a mutation in the PDZ domain of PRG (V106E) to 
disrupt PBD-PDZ interaction (Figure 45). OptoPlexin failed to recruit PDZ(V106E) 
indicating that PDZ-PBD interaction is necessary for recruitment. To examine 
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C-terminus FP 
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(constructs used in experiments) 
 
Figure 45. Functional domains of PDZ-RhoGEF. Domain organization of PDZ-
RhoGEF and its mutants that were used in this study. FP, fluorescent protein.   
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Figure 46. RhoGEF co-recruitment assay. Assay used to probe interaction between 
PRG and Plexin-B1 
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Figure 47. Rac1 association with Plexin-B1 promotes RhoGEF recruitment. 
Relative co-recruitment of (a) PRG and (b) LARG by optoPlexin with or without 
overexpression of caRac1. (c) Relative increase in membrane localization of 
mVenus-PRG upon illumination of optoPlexin, Cry2-mCherry-caRac1 or mCer3-
Pa-Rac1. Note that for (c) pa-Rac1 is tethered to the membrane. The 
fluorescence signal of mVenus-PRG after one minute of blue light illumination 
was normalized to that before illumination. n>15. mean ± s.e.m.  *** p<0.001 [ 
there is no single asterisks on the figure. 
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Figure 48. Plexin-B1-RBD is a regulatory switch for PDZ-RhoGEF recruitment. 
(a) Relative co-recruitment of PRG by optoPlexin, optoPlexin-GGA and 
optoPlexin-L1799F with or without overexpression of ca-Rac1. (b) Relative 
co-recruitment of PRG by optoPlexin mutants. n>15. mean ± s.e.m.  *** 
p<0.001, * p<0.05. 
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whether the PBD alone is sufficient for PRG recruitment, we developed a 
construct with the C-terminal 10 residues of Plexin-B1 tethered to Cry2 
(optoPlexin-PBD, figure 21). We reasoned that if Rac1 binding exposed a cryptic 
PBD, then optoPlexin-PBD ought to efficiently recruit PRG. We found that 
optoPlexin-PBD fail to recruit PRG (Figure 48b). Additional interactions between 
the PDZ domain of PRG and the RasGAP domain of B-plexins have been 
proposed to stabilize PDZ binding178. Nevertheless, tethering the 20 C-terminal 
residues of Plexin-B1, which included the additional interaction sites with PDZ 
domain (Figure 21), to Cry2 did not significantly rescue the recruitment of PRG 
(Figure 48b). It is likely that the PBD requires an intact RasGAP domain to 
stabilize the extended binding interface with PDZ and the above isolated PBDs 
may not be sufficient. Although crystal structures of B-family plexins did not 
indicate a cryptic PBD, the PBD could be cryptic in cells in the presence of other 
proteins. To investigate whether caRac1 binding affects the Plexin-B1-PDZ 
interaction, we utilized the PDZ domain of PRG (Figure 45) in the co-recruitment 
assay. Unexpectedly, co-expression of caRac1 did not promote recruitment of 
the PDZ domain (Figure 49a). Moreover, optoPlexin-GGA and optoPlexin-
L1799F showed recruitment of PDZ domain not statistically different from the WT 
optoPlexin (Figure 49b). These data indicated that Rac1 promotion of PRG 
recruitment was not effected through increased PBD-PDZ binding.  
Our data indicated that the PBD interaction, although necessary, was not 
sufficient for robust recruitment of PRG by Plexin-B1, suggesting that there might 
be additional interactions between Plexin-B1 and PRG. In both PRG and LARG 
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the N-terminal PDZ domain is followed by an RGS-like domain, catalytic DH-PH 
domain and an extended C-terminus. Particularly, the C-terminus and the RGS-
like domain of PRG have been reported to mediate protein-protein interactions. 
The extended C-terminus of PRG and LARG mediates homo and hetero-
oligomerization between PRG, LARG and p115-RhoGEF and may play a role in 
oncogenic transformation179. Furthermore, a proline-rich region in the C-terminus 
of PRG has been reported to bind with the SH3 domain of Phospholipase C–γ, 
whose SH2 domains bind to phosphorylated tyrosine residues in Plexin-B1149. 
We have previously shown that the tyrosine residues that mediate interaction 
with Phospholipase-Cγ are not critical for PRG recruitment by optoPlexin, RhoA 
activation, or optoPlexin mediated repulsion in migrating cells (Figure 26g, 28, 
35). Furthermore, the proline-rich sequences in PRG are not conserved in LARG, 
further suggesting that these sequences are not critical for Rac1 mediated 
increase in PRG and LARG recruitment. The RGS-like domain is utilized by Gα12 
and Gα13 components of G-protein coupled receptors to recruit PRG, LARG and 
p115-RhoGEF. However unlike those of p115-RhoGEF and LARG, the RGS-like 
domain of PRG lacks GAP activity for Gα12 and Gα13180. Unlike the PDZ domain, 
optoPlexin did not efficiently recruit the RGS-like domain of PRG (Figure 45) 
indicating that if present, any direct interactions with Plexin-B1 are significantly 
weaker than the Plexin-B1-PDZ binding or require PDZ domain interaction 
(Figure 50b,c). To investigate whether in the presence of the PDZ domain the 
RGS-like domain might mediate recruitment by Plexin-B1, we utilized the PDZ-
RGS domains in recruitment assay (Figure 45). The PDZ-RGS domain was 
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efficiently recruited by optoPlexin, and co-expression of caRac1 increased the 
recruitment levels (Figure 49c). Moreover, optoPlexin-GGA failed to recruit PDZ-
RGS domains whereas optoPlexin-L1799F showed very efficient recruitment 
levels, comparable to recruitment by optoPlexin in the presence of caRac1 
(Figure 49d). Thus the PDZ-RGS domain recapitulated the Rac1 regulation of 
PRG recruitment indicating a role of RGS domain in Plexin-B1-PRG interaction.  
The RGS-like domain of PRG interacts with GTP-loaded Gα13 through two 
distinct sites, which are conserved in LARG and p115-RhoGEF174. We 
speculated that these sites might also play a role in PRG recruitment by Plexin-
B1. To investigate this possibility we introduced a mutation in the RGS-box 
subdomain of the RGS-like domain of PRG (L467Q) (Figure 45) to disrupt 
interaction with Ras-like domain of Gα12 and Gα13. To validate the mutation, we 
tethered a constitutive mutant of Gα12 to Cry2 (Cry2-Gα12) and utilized it for in-cyto 
recruitment of PRG and its sub-domains. Cry2-Gα12 efficiently recruited PRG, as 
well as the RGS-like domain, but not the PDZ domain of PRG (Figure 50a,b,c) 
demonstrating that Cry2-Gα12 interacted with PRG similar to GTP-loaded Gα12 
and Gα13. In addition, Cry2-Gα12 did not show any defects in recruitment of 
PRG(V106E), suggesting that the PDZ domain does not significantly contribute 
to association of PRG with Gα12 (Figure 50d). As expected Cry2-Gα12 failed to 
recruit PRG(L467Q), thus validating the efficacy of the mutation. OptoPlexin 
failed to recruit PRG(L467Q). These data further supported an inhibitory role of 
the RGS-like domain in PDZ-PBD interaction (Figure 51).  
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Figure 49. Rac1 regulation of PDZ-RhoGEF recruitment by Plexin-B1 is effected by 
the RGS domain. Relative co-recruitment of (a) PDZ domain and (c) PDZ-RGS domain 
by optoPlexin with or without overexpression of ca-Rac1. Relative co-recruitment of 
(b) PDZ domain and (d) PDZ-RGS domain by optoPlexin, optoPlexin-GGA and 
optoPlexin-L1799F. n>15. mean ± s.e.m.  *** p<0.001, * p<0.05. 
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Figure 50. RGS domain mediates PDZ-RhoGEF association with both Gα12 and Plexin-
B1. Relative co-recruitment of (a) PRG, (b) PDZ domain, (c) RGS domain, (d) 
PRG(V106E), (e) and (f) PRG(L467Q) by optoPlexin and Cry2-Gα12. n>15. mean ± 
s.e.m.  *** p<0.001, * p<0.05. 
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Figure 51. Proposed model for regulation of PRG recruitment through 
RBD of Plexin-B1. RGS may inhbit interaction between PDZ and PBM 
(same as PBD). RBD may inhibit interaction between the RGS domain 
and the RasGAP domain. This inhibition may be relieved upon Rac1 or 
Rnd1 binding to RBD. 
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Discussion and future directions: B family plexins utilize their C-terminal PBD 
to recruit PRG and LARG through what was thought to be a constitutive 
interaction with the PDZ domain of these RhoGEFs68. Our data suggests that 
PBD-PDZ interaction between Plexin-B1 and PRG is not constitutive, and is 
regulated by GTPase binding to Plexin-RBD. Lack of recruitment of PRG by 
optoPlexin-PBD indicated that the canonical PBD-PDZ interaction is not sufficient 
for efficient PRG recruitment, which is consistent with the low affinity (~ 30 μM) of 
bindng between PBD and PDZ domain178. Additional interactions between the 
RasGAP domain and the PDZ domain have been reported to significantly boost 
the affinity between Plexin-B1 and PDZ domain ( to ~ 3 μM). This is reflected in 
our data wherein unlike optoPlexin, optoPlexin-PBD failed to efficiently recruit 
PRG. Regardless, these additional PDZ interactions do not explain why co-
expression of caRac1 promoted recruitment of PRG and PDZ-RGS, but not of 
the PDZ domain alone. GTPase binding to Plexin-B1 is known to mediate its 
RasGAP activity63. Our data demonstrate a role of GTPase binding in RhoGEF 
recruitment. Furthermore, optoPlexin-GGA, which contains all the identified 
interaction sites between PDZ domain and PRG, recruited the PDZ domain 
efficiently, but not PRG or PDZ-RGS. Finally, mutating one of the known 
interaction sites between PRG-RGS-like domain and Gα12/13 abrogated PRG 
recruitment by optoPlexin. Taken together, these observations suggest a model 
where the RGS-like domain hinders PDZ-binding, through direct obstruction of 
the PBD-interaction or through allosteric inhibition (Figure 51). This obstruction is 
presumably relieved through some hitherto unknown interaction with Plexin-B1, 
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which is mediated by the Plexin-B1-RBD. Truncation of the RBD did not impact 
PRG or PDZ-RGS recruitment suggesting that it did not directly associate with 
the RGS domain. Since truncation of the juxtamembrane helix also did not 
impact PRG recruitment levels, we hypothesize that the RGS-like domain 
interacts with the RasGAP domain of Plexin-B1. Lack of efficient recruitment of 
the RGS-like domain with optoPlexin or any of its mutants suggests that the 
interaction is significantly weaker than that with PDZ domain. A pull-down assay 
might be appropriate to examine any interactions between purified Plexin-B1 (or 
its mutants) intracellular domain and the RGS-like domain of PRG. It is, of 
course, possible that Gα12 or Gα13 might co-operate with the Plexin-B1 signaling 
complex to respectively bind to the RGS-like and PDZ domain. Failure of 
optoPlexin in recruiting PRG(V106E) suggests that any association of the Plexin-
B1 complex with the RGS domain is significantly weaker than the PDZ-PBD 
interaction, which is weaker than Gα12 or Gα13 association with RGS domain. This 
argues against a role of Gα12 or Gα13 GTPases in Plexin-B1 recruitment of PRG, 
since even in the absence of PDZ-PBD interaction, Gα12 or Gα13 associated with 
optoPlexin should have been able to recruit PRG(V106E).  
Recently, Plexin-D1 has been reported to bind to GIPC1 (GAIP interacting 
protein, C-terminus 1) through the C-terminal PBD of Plexin-D1 and PDZ domain 
of GIPC1181. In the native state, GIPC1 exists in a dimerized state where the 
GH1 and GH2 domains that flank the PDZ domain inhibit interaction with Plexin-
D1 C-terminal PBD. Our observations suggesting an inhibitory role of the RGS-
like domain in mediating PDZ-PBD interaction appears, at least superficially, to 
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be similar in nature and might be another mode of conferring specificity to PDZ-
PBD interactions. Investigating mechanisms that regulate interactions between 
other PDZ domain and PBD containing proteins might yield hints about Plexin-B1 
and PRG regulation as well. GTPase binding does not significantly alter the 
conformation of the isolated Plexin-RBD182. Such binding may, however, relieve 
autoinhibition of the Plexin RasGAP domain by facilitating oligomerization 
wherein the RBD no longer blocks interaction between the RasGAP domain and 
GTP-loaded Ras or Rap proteins. GTPase binding may also induce 
conformational changes in the RasGAP domain to promote or stabilize its binding 
to small GTPases. Whether the same residues in the Plexin-B1 RasGAP domain 
might regulate interaction between small GTPases and PRG remains 
unexplored. While the plexins show remarkable homology in their intracellular 
domains, there are subtle differences that might explain their specificities for 
different Rho and Ras GTPases. In particular, all plexins have a conserved 
leucine residue (L1658 in Plexin-B1) in the RasGAP region that might directly 
interact with the GTP in GTP-loaded Ras or Rap proteins. In A family plexins, the 
L1658 residue is exposed to freely interact with GTP. However in B family 
plexins, a conserved tyrosine residue (Y1651 in Plexin-B1) appears to interact 
with L1658, and might regulate its interaction with GTP-Ras. Substituting the 
amino acid sequence in Plexin-B1 that spans through Y1651 with the 
corresponding sequence in Plexin-A1 and investigating PRG recruitment by the 
resultant protein might provide information regarding the role of these sites in 
PRG recruitment. If this indeed were the site of additional PRG interaction, it 
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would be interesting to examine whether GTP-Ras and PRG binding to Plexin-B1 
are competitive or co-operative. 
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Materials and methods:  
Cell culture and transfection. All the experiments in chapter II were performed 
on COS7 cells. COS-7 cells were obtained from American Type Culture 
Collection (ATCC) and were cultured in DMEM (Lonza, Basel, Switzerland) basal 
media, and were passaged every third day of culture. For optimal growth, the 
media were supplemented with 10% (v/v) FBS (Gibco, Billings, MO) and 
Penicillin/Streptomycin (Lonza), and the cells were maintained under standard 
cell culture conditions (37°C and 5% CO2). The cell lines were regularly checked 
for mycoplasma contamination. FuGENE 6 reagent (Promega, Madison, WI) was 
used for transient transfections according to manufacturer’s instructions. 
DNA plasmids.  psd44-G12QL (caGα12) was a gift from Agnese Mariotti (Addgene 
plasmid # 46825). OptoPlexin and optoPlexin mutants, PRG and LARG plasmids 
were generated as described in the materials and methods section of chapter II. 
Additional optoPlexin and PRG mutants were generated using overlapping 
polymerase chain reaction (PCR). Cry2-caRac1 and Cry2-caGα12 were designed in 
a manner similar to optoPlexin. Briefly, Cry2 was positioned at the N-terminus and 
caRac1 or caGα12 at the C-terminus. For the co-recruitment assay, Cry2 plasmids 
were tethered to mCherry and RhoGEF plasmids were tethered to mVenus. These 
constructs were initially subcloned into the pTriEx-4 vector (Novagen) using PCR 
and restriction digestion. Unless specified otherwise, the termini of tagging were 
positioned as in the orders they were written. The open reading frames of all DNA 
plasmids were verified by DNA sequencing. 
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Imaging setup.  All time-lapse imaging were performed on a customized Nikon 
Ti-E inverted microscope. TIRF imaging was performed using a 60x oil TIRF 
objective (NA 1.49). The microscope was modified with a “stage-up” design 
which enables an insertion of two independent, motorized dichroic mirrors/filter 
cubes in the microscope infinity space. A dichroic mirror in the bottom cube was 
used to reflect excitation laser lines at 442, 514, 594 nm for imaging of 
mCerulean, mVenus, and mCherry respectively. The laser lines were launched 
from a fiber-coupled LMM5 system (Andor) equipped with an acousto-optic 
tunable filter (AOTF) for shutter and intensity control. Another dichroic mirror 
(495LP) in the top cube was used to bring in optogenetic illumination originated 
from a LED source at 440 nm (CoolLED). The 495LP mirror permitted immediate 
acquisition of mVenus or mCherry after optogenetic illumination. Alternatively, 
the top mirror can be rotated out to a blank position for Patterned illumination 
was generated using a commercial digital mirror device (Mosaic, Andor). The 
fluorescent emission was captured with an EMCCD camera (iXon Ultra, Andor). 
Metamorph software was used to control the imaging set up. Live cell imaging 
was performed at 37°C in a heated chamber (Bioptechs) with humidified 5% CO2 
supply. Vitamin and phenol red-free media (US Biological) supplemented with 
2% FBS were used in imaging to reduce background and photobleaching.  
Membrane recruitment assay. Co-recruitment of PRG and its variants by 
optoPlexin and it variants, and Cry2-Gα12 were assessed as described in Chapter 
II. Activation of paRac1 does not involve any membrane translocation. So, 
recruitment levels of PRG by Cry2-caRac1 and paRac1 were assessed by the 
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change in TIRF intensity of mVenus (tethered to PRG) after 100 seconds of blue 
light illumination relative to that before illumination. 
Statistical analyses. Microsoft Excel and Matlab were used for statistical 
analyses. Sample sizes for different experiments were chosen based on the 
commonly used range in the field without conducting any statistical power 
analysis. Normal probability plot function of Matlab was utilized to confirm normal 
distribution of the data. Sample means and standard error of mean was 
calculated and shown on the graphs. P values were obtained from one-tailed 
Students t-test.  
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Chapter IV 
General discussion and future directions  
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Spatial and temporal regulation is fundamental for coordination of signaling 
pathways that mediate physiological phenomena. Dysregulation of either can lead 
to development of pathologies. In this work, we investigated coordination of 
osteoblast migration by osteoclasts upon direct contact between the cells and 
elucidated spatiotemporal regulation of pathways that mediate resulting osteoblast 
response.  
Further roles of CIL in bone remodeling. Bone remodeling is initiated by 
migration of osteoclasts to a site with damaged bone matrix and start resorption. 
How osteoclasts identify and migrate to these sites is a topic of extensive research, 
and is beyond the scope of this work. Osteoclasts are derived from hematopoietic 
lineage progenitors that differentiate towards macrophage-monocytic lineage upon 
exposure to macrophage-colony stimulating factor (MCSF), which is expressed by 
osteoblast lineage cells. While full-length MCSF precursor is membrane-tethered, 
the extracellular domain may be proteolytically cleaved to produce a soluble 
cytokine. These ‘pre-osteoclasts’ must come in contact with osteoblastic cells for 
RANKL stimulation, which is necessary for osteoclastogenesis. RANKL stimulates 
Sema4D expression in pre-osteoclasts, and this event may initiate the segregation 
of osteoblastic and osteoclastic cells, which persists through the rest of the bone 
remodeling cycle. Drosophila macrophages have been reported to undergo 
homotypic CIL37,56, which facilitates its spread through the animal body. If 
osteoclast precursors also undergo similar homotypic CIL, either MCSFor RANKL 
stimulation may be expected to downregulate the factors that mediate such CIL, 
since homotypic CIL may render the fusion of the pre-osteoclasts very inefficient. 
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 In addition to Plexin-B1 and Plexin-B2, osteoblastic cells also 
express their ligand, Sema4D15. The role of osteoblastic Sema4D in its motility and 
function is not understood. It is conceivable that homotypic CIL between 
osteoblasts may facilitate collective migration. In addition, Sema4D from 
osteoblasts undergoing collective motion may also act to keep the cells in a 
relatively undifferentiated state until the target site has been reached. Since 
Sema4D extracellular domain may be cleaved to obtain a soluble ligand183, it may 
also act as a decoy ligand to compete against Sema4D expressed by other cells in 
the bone microenvironment. However the significance of Sema4D expressed by 
osteoblasts in migration and differentiation in vivo remains to be further 
investigated. 
Spatial regulation of β-Pix in cell repolarization. In chapter II, we 
demonstrated spatial regulation of β-Pix in osteoblastic cells undergoing 
repolarization. β-Pix associates with Paxilin in adhesions through Git-1184. Our data 
suggest that β-Pix association with focal adhesions is negatively responsive to 
mechanical tension. To test whether β-Pix or Git1 responds to mechanical tension, 
we treated MC3T3-E1 cells expressing mCherry-Paxilin and mVenus-Git1 with Y-
27632 ROCK inhibitor. Unlike β-Pix, Git1 showed a decrease in association with 
adhesions (Figure 52a). These data suggest that in response to RhoA-ROCK 
signaling, β-Pix dissociates from the Git1-Paxilin complex (Figure 52b), which in 
turn suggests that there might be a change in the state of either β-Pix or Git1 
downstream of ROCK signaling. Indeed, if β-Pix redistribution during CIL is 
mediated by mechanical tension, our data would suggest the presence of a 
 143 
  
  
Figure 52. RhoA-ROCK mediates dissociation of β-Pix from Git1-Paxilin complex. (a) 
Changes in mCer3-Paxillin, mVenus-β-Pix and mCherry-Git1 in MC3T3-E1 cells on 10 
μM Y-27632 ROCK inhibitor treatment, normalized to values prior to treatment. (b) 
Cartoon representation of the proposed model of β-Pix dissociation. n = 7 cells, 
mean ± s.e.m.  
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mechanosensitive element in either β-Pix or Git1, which directly responds to 
mechanical tension, or acts as a substrate to another enzyme that does. Further 
investigation into the signaling pathways that mediate β-Pix dissociation from Git1-
Paxilin complex may provide interesting insight into how cells respond to 
mechanical tension. 
Rac1 regulation of RhoGEF recruitment by Plexin-B1. Our data on the 
effect of GTP-loaded Rac1 on facilitating PRG recruitment by Plexin-B1 
demonstrates a role of Plexin-B1 in integrating extracellular and intracellular 
signals to modulate cell response to its environment. Rac1 promotes actin 
polymerization and protrusions. By regulating PRG recruitment and activation by 
Plexin-B1, Rac1 provides a distinct spatial control of Plexin-B1, presumably 
localizing it to active protrusions, and minimizing any impact of Sema4D 
stimulation in non-protruding regions in a cell. Additionally, Rac1 and RhoA are 
generally thought to inhibit one another55. Thus, in Sema4D-Plexin-B1 signaling, 
Rac1 may act as a switch to rapidly convert a region of high Rac1 and low RhoA 
activity to one of high RhoA and low Rac1 activity. Such a change may facilitate 
rapid induction of CIL, enabling cells to efficiently respond to extracellular cues. 
Our data implicates the RGS domain of PRG in Rac1 regulation of Plexin-B1 
signaling. This provides an interesting intersection of signaling cascades initiated 
by heterotrimeric G proteins and Plexins. Whether these two pathways compete for 
available RhoGEFs in a cell remains to be investigated. Although the exact 
mechanism by which PRG or LARG is activated by either pathways is not 
completely understood. Although mere plasma membrane recruitment of PRG may 
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be sufficient for activation185, such recruitment clearly involves the RGS domain. 
Further investigation of both plexins and G-protein signaling may help elucidate the 
molecular mechanism of PRG and LARG activation. 
In chapter II, I investigated the underlying signaling pathways that mediate 
spatial segregation of osteoblasts and osteoclasts in vivo. Using a co-culture 
system, I have demonstrated that osteoblasts undergo CIL upon contact with 
osteoclasts. Applying gene editing techniques, I have established a role of Plexin-
B1 signaling in mediating said CIL, and by utilizing an optogenetic tool I have 
demonstrated that localized activation of Plexin-B1 signaling is capable of 
recapitulating the CIL-like behavior that osteoblasts exhibit upon contact with 
osteoclasts. The stark contrast between a collapse phenotype upon whole cell 
stimulation and cell repolarization upon localized stimulation underscores the 
necessity of investigating spatial regulation of signaling pathways to better 
understand their roles in cell behavior. Since Plexins show remarkable homology in 
their intracellular domains, the design for optoPlexin, pertinent to Plexin-B1, should 
be extendable to other plexins as well. In chapter III, I have explored the regulation 
of Plexin-B1 signaling by GTP-Rac1 association with Plexin-B1-RBD. Utilizing a 
co-recruitment assay of PRG with optoPlexin, I have demonstrated that GTP-Rac1 
association with Plexin-B1 mediates PRG recruitment. Utilizing various mutations 
of optoPlexin and PRG, I have identified a role of the RGS domain of PDZ-
RhoGEF in Plexin-B1-PRG association. Overall, these new findings increase our 
understanding of the nature of interactions between osteoclasts and osteoblasts, 
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the role of Plexin-B1 signaling and spatiotemporal regulation of other signaling 
molecules in CIL, and molecular mechanisms that mediate Plexin signaling.  
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List of movies: 
 
Movie 1: Spatial segregation between an osteoclast and primary osteoblasts. 
Primary murine calvarial osteoblasts were co-cultured with murine osteoclasts and 
imaged using phase contrast at 5 minute intervals. Scale bar, 50 μm. 
Movie 2: Osteoblast undergoing CIL on contact with osteoclast. Primary 
murine calvarial osteoblasts migrating towards murine osteoclasts were imaged 
using phase contrast at 5 minute intervals. Scale bar, 50 μm. 
Movie 3: MC3T3-E1 cell undergoing CIL on contact with osteoclast.  MC3T3-
E1 osteoblastic cells migrating towards murine osteoclasts were imaged using 
phase contrast at 5 minute intervals. Scale bar, 50 μm. 
Movie 4: MC3T3-E1 cell on contact with a bone marrow macrophage.  MC3T3-
E1 osteoblastic cells migrating towards murine BMMs were imaged using phase 
contrast at 5 minute intervals. Scale bar, 50 μm. 
Movie 5: Cas9 MC3T3-E1 cell undergoing CIL on contact with osteoclast. 
Cas9 expressing MC3T3-E1 cells encountering murine osteoclasts were imaged 
using phase contrast at 2 minute intervals. Scale bar, 50 μm. 
Movie 6: KO1 MC3T3-E1 cell CIL on contact with osteoclast.  Plexin-B1 null 
KO1 MC3T3-E1 cells migrating towards murine osteoclasts were imaged using 
phase contrast at 2 minute intervals. Scale bar, 50 μm. 
Movie 7: KO2 MC3T3-E1 cell CIL on contact with osteoclast.  Plexin-B1 null 
KO2 MC3T3-E1 cells were co-cultured with murine osteoclasts and imaged using 
phase contrast at 2 minute intervals. Scale bar, 50 μm. 
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Movie 8: Clustering of Plexin-B1-mCherry around Sema4D-Fc silica beads. 
COS-7 cells were transfected with Plexin-B1-mCherry and Sema4D-Fc silica 
beads were added to the culture. Contact between the beads and the cells, and 
subsequent changes in mCherry fluorescence distribution were observed using 
using 60X objective at 1 minute intervals. Scale bar, 10 μm.   
Movie 9: Translocation of optoPlexin to the plasma membrane upon blue 
light illuminaton. The fluorescence intensities of mCherry-optoPlexin or mCherry-
optoPlexin(D393A) in COS-7 cells were imaged using TIRFM upon whole cell 
illumination at 440 nm and at 10 second intervals. The cells were coexpressing 
CIB-mEGFP-CAAX. Scale bar, 10 μm.   
Movie 10: Corecruitment of PRG with optoPlexin upon whole cell 
illumination. Representative TIRF images showing simultaneous changes in 
membrane intensity of mCherry-optoPlexin and mVenus-PRG in COS-7 cells upon 
whole cell illumination with 440 nm light at 10 second intervals. The COS-7 cells 
were transiently expressing CIB-CAAX, mCherry-optoPlexin and mVenus-PRG. 
Timestamp shows minutes and seconds post illumination. Scale bar, 10 μm.   
Movie 11: Induction of CIL upon local activation of optoPlexin. DIC and TIRF 
images showing local activation of mCherry-optoPlexin and subsequent induction 
of CIL in MC3T3-E1 cells. mEGFP-CIB-CAAX and mCherry-optoPlexin were 
transiently expressed in MC3T3-E1 cells and in one such migrating cell, mCherry-
optoPlexin was stimulated at a protrusion using localized 440 nm light illumination 
at 10 second intervals. Timestamp shows minutes and seconds post illumination. 
Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm. 
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Movie 12: Local optoPlexin stimulation induces change in direction in a 
migrating cell. DIC and TIRF images showing local activation of mCherry-
optoPlexin and subsequent change in direction of migration in MC3T3-E1 cells. 
CIB-CAAX and mCherry-optoPlexin were transiently expressed in MC3T3-E1 cells 
and mCherry-optoPlexin was stimulated at a protrusion using localized 440 nm 
light illumination at 20 second intervals. Timestamp shows minutes and seconds 
post illumination. Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 
10 μm.   
Movie 13: Local stimulation of optoPlexin-delPBD. DIC and TIRF images 
showing local accumulation of mCherry-optoPlexin-delPBD but no induction of CIL 
in a MC3T3-E1 cell. mEGFP-CIB-CAAX and mCherry-optoPlexin-delPBD were 
transiently expressed in MC3T3-E1 cells. OptoPlexin-delPBD was stimulated at a 
protrusion using localized 440 nm light illumination at 10 second intervals. 
Timestamp shows minutes and seconds post illumination. Magenta circle, region of 
illumination (diameter, 5 μm). Scale bar, 10 μm. 
Movie 14: Induction of cell collapse upon whole cell activation of optoPlexin. 
DIC and TIRF images showing activation of mCherry-optoPlexin and subsequent 
morphological changes in MC3T3-E1 cells upon stimulation using 440 nm light 
illumination at 10 second intervals throughout the field of view. The MC3T3-E1 
cells were transiently expressing mEGFP-CIB-CAAX and mCherry-optoPlexin. 
Timestamp shows minutes and seconds post illumination. Scale bar, 10 μm.  
Movie 15: Co-recruitment of PRG with optoPlexin upon local illumination. 
TIRF images showing changes in membrane intensity of mCherry-optoPlexin and 
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mVenus-PRG upon localized illumination (as indicated by white arrowhead) with 
440 nm light at 10 second intervals. MC3T3-E1 cells were transiently expressing 
CIB-CAAX, mCherry-optoPlexin and mVenus-PRG. Timestamp, minutes after 
illumination. Scale bar, 10 μm.  
Movie 16: Polarized distribution of MyoRLC upon local optoPlexin activation. 
TIRF images showing localized activation of mVenus-optoPlexin and subsequent 
changes in mCherry-MyoRLC distribution. CIB-CAAX, mVenus-optoPlexin and 
mCherry-myoRLC were transiently expressed in MC3T3-E1 cells. mCherry-
OptoPlexin was stimulated at a protrusion using localized 440 nm light illumination 
at 10 second intervals. Timestamp shows minutes and seconds post illumination. 
Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm.   
Movie 17: Local stimulation of optoPlexin-RA. DIC and TIRF images showing 
local accumulation of mCherry-optoPlexin-RA but no induction of CIL in a MC3T3-
E1 cell. mEGFP-CIB-CAAX and mCherry-optoPlexin-delPBD were transiently 
expressed in MC3T3-E1 cells. OptoPlexin-RA was stimulated at a protrusion using 
localized 440 nm light illumination at 10 second intervals. Timestamp shows 
minutes and seconds post illumination. Magenta circle, region of illumination 
(diameter, 5 μm). Scale bar, 10 μm. 
Movie 18: Local stimulation of optoPlexin-YF. DIC and TIRF images showing 
local activation of mCherry-optoPlexin-YF and subsequent induction of CIL in 
MC3T3-E1 cells. CIB-CAAX and mCherry-optoPlexin were transiently expressed in 
MC3T3-E1 cells and in one such migrating cell, mCherry-optoPlexin-YF was 
stimulated at a protrusion using localized 440 nm light illumination at 10 second 
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intervals. Timestamp shows minutes and seconds post illumination. Magenta 
circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm. 
Movie 19: Mobilization and redistribution of β-Pix upon local activation of 
optoPlexin. TIRF images showing redistribution of mVenus-β-Pix upon localized 
activation of mCherry-optoPlexin in a MC3T3-E1 cell. CIB-CAAX, mCherry-
optoPlexin and mVenus-β-Pix were transiently expressed in MC3T3-E1 cells. 
mVenus-optoPlexin was stimulated at a protrusion using localized 440 nm light 
illumination at 10 second intervals. Timestamp shows minutes and seconds post 
illumination. Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10 
μm.   
Movie 20: Effects of local activation of optoPlexin on adhesions. TIRF images 
showing changes in mCherry-Paxillin distribution upon localized activation of 
mVenus-optoPlexin in a MC3T3-E1 cell. CIB-CAAX, mVenus-optoPlexin and 
mCherry-Paxillin were transiently expressed in MC3T3-E1 cells. mVenus-
optoPlexin was stimulated at a protrusion using localized 440 nm light illumination 
at 10 second intervals. Timestamp shows minutes and seconds post illumination. 
Magenta circle, region of illumination (diameter, 5 μm). Scale bar, 10 μm.  
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